Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

C
Cabeza, Beatriz

Hospital Clínico San Carlos
(P 515) ENDOBRONCHIAL NAVIGATION AS AN INTRAOPERATORY TOOL FOR RESECTION OF SMALL PULMONARY METASTASES IN SARCOMA PATIENTS
Beatriz Cabeza
Favorite
Cabrera, Maria

Hospital Clinico san Carlos
(P 149) PSYCOLOGICAL SNAPSHOT OF SARCOMA PATIENTS FROM AN ACADEMIC, UNIVERSITY CENTER, HOSPITAL CLÍNICO SAN CARLOS (HCSC), MADRID, A SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN
Maria Cabrera
Favorite
Cacciamali, Andrea

Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Laboratorio di Controllo di Prodotti Biologici, Centro di Referenza Nazionale per i Metodi Alternativi, Benessere e Cura degli Animali da Laboratorio
(P 283) A TRIDIMENSIONAL PRECLINICAL MODEL TO STUDY HUMAN AND CANINE OSTEOSARCOMA DEVELOPMENT AND INTERACTION WITH TUMOR MICROENVIRONMENT
Andrea Cacciamali
Favorite
Caccin, Elisabetta

Centro di Riferimento Oncologico (CRO), IRCCS
(P 144) IMPLEMENTATION OF THE EUROPEAN CLINICAL TRIAL REGULATION: SURVEY OF THE ITALIAN SARCOMA GROUP CENTERS
Elisabetta Caccin
Favorite
Cagnazzo, Celeste

AOU Città della Salute e della Scienza Presidio Ospedaliero Infantile Regina Margherita
(P 144) IMPLEMENTATION OF THE EUROPEAN CLINICAL TRIAL REGULATION: SURVEY OF THE ITALIAN SARCOMA GROUP CENTERS
Celeste Cagnazzo
Favorite
Cagney, Gerard

University College Dublin
(P 424) INTERNAL TANDEM DUPLICATION OF BCOR (BCOR-ITD) ALTERS THE TUMOR EPIGENOME
Gerard Cagney
Favorite
Cai, Kathy

Fox Chase Cancer Center
(P 287) ESTABLISHMENT AND GENOMIC VALIDATION OF NOVEL PATIENT-DERIVED XENOGRAFT MODELS FOR DRUG DISCOVERY IN GASTROINTESTINAL STROMAL TUMOR
Kathy Cai
Favorite
Calabrese, Chiara

Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" IRST IRCCS, Preclinic and Osteoncology Unit, Meldola, Italy
(P 37) DISSECTING THE ROLE OF EXTRACELLULAR VESICLES IN THE MANAGEMENT OF GIST
Chiara Calabrese
Favorite
(P 253) THE EFFICACY OF MEDICATED PATCHES IN SOFT TISSUE SARCOMAS: IN-VITRO AND EX-VIVO VALIDATION.
Chiara Calabrese
Favorite
Calaminus, Gabriele

University Hospital Bonn
(P 538) IEUROEWING TRIAL FOR LOCALIZED AND METASTATIC EWING SARCOMA
Gabriele Calaminus
Favorite
Caldari, Emilia

Ospedale Morgagni Pierantoni
(P 533) SAFETY AND PRELIMINARY BIOLOGICAL ACTIVITY OF A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION IN SARCOMAS.
Emilia Caldari
Favorite
Calder, Paul

Memorial Sloan Kettering Cancer Center
(P 289) IDENTIFICATION OF EFFECTIVE THERAPEUTIC COMBINATIONS WITH THE NUCLEAR EXPORT PROTEIN INHIBITOR, SELINEXOR, IN PEDIATRIC SOLID TUMORS
Paul Calder
Favorite
Califano, Andrea

Department of Systems Biology, Biomedical Informatics, Biochemistry and Molecular Biophysics, and Medicine, Herbert Irving Comprehensive Cancer Center, Columbia University
(P 289) IDENTIFICATION OF EFFECTIVE THERAPEUTIC COMBINATIONS WITH THE NUCLEAR EXPORT PROTEIN INHIBITOR, SELINEXOR, IN PEDIATRIC SOLID TUMORS
Andrea Califano
Favorite
Calizo, Ana

Johns Hopkins University
(P 250) SHARING HIGH-QUALITY SAMPLES AND DATA TO THE NF1 RESEARCH COMMUNITY: THE ROLE OF THE JOHNS HOPKINS NF1 BIOSPECIMEN REPOSITORY
Ana Calizo
Favorite
Callahan, Carson

The University of Texas MD Anderson Cancer Center
(P 269) PLASMA DNA METHYLATION-BASED BIOMARKERS FOR MPNST DETECTION IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1)
Carson Callahan
Favorite
Callegaro, Dario

Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 126) CURRENT PRACTICE IN SPERMATIC CORD SARCOMA: ONCOLOGICAL TIMELINES AND OUTCOMES ACCORDING TO INITIAL RESECTIONS PERFORMED AT A LOCAL HOSPITAL VERSUS EARLY PATIENT REFERRAL TO A TERTIARY CENTRE.
Dario Callegaro
Favorite
(P 329) DISTANT METASTASIS IN RETROPERITONEAL LEIOMYOSARCOMA: TUMOR SIZE, GRADE AND MORE?
Dario Callegaro
Favorite
(P 410) PROTEOMICS ANALYSIS IDENTIFIES A SIGNATURE THAT IMPROVES PROGNOSTIC RISK STRATIFICATION OF THE SARCULATOR NOMOGRAM IN PATIENTS WITH SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND TRUNK WALL
Dario Callegaro
Favorite
(P 431) TREATMENT STRATEGY AND PROGNOSTIC FACTORS IN EXTRASKELETAL EWING SARCOMA: AN INSTITUTIONAL RETROSPECTIVE ANALYSIS
Dario Callegaro
Favorite
(P 455) EXTRASKELETAL EWING SARCOMA: A MULTICENTRIC RETROSPECTIVE STUDY FROM THE ITALIAN SARCOMA GROUP
Dario Callegaro
Favorite
Calles Blanco, Antonio

Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
(P 517) PULMONARY METASTASECTOMY FOR SARCOMA: A SINGLE-INSTITUTION EXPERIENCE
Antonio Calles Blanco
Favorite
Call, Jerry

The Life Raft Group
(P 33) LONGITUDINAL FOLLOW UP OF GASTROINTESTINAL STROMAL TUMORS:DATA FROM THE LIFE RAFT GROUP INTERANTIONAL PATIENT REGISTRY
Jerry Call
Favorite
Calore, Federica

The Ohio State University Comprehensive Cancer Center
(P 335) EXTRACELLULAR VESICLE MDM2 DNA AS A BIOMARKER OF TUMOR PRESENCE AND RECURRENCE IN RETROPERITONEAL LIPOSARCOMA
Federica Calore
Favorite
Calpona, sebastiano

Irst
(P 364) EVALUATION OF THE PREDICTIVE ROLE OF SYSTEMIC AND INTRATUMORAL IMMUNITY IN PATIENTS WITH LOCALIZED LIPOSARCOMAS, MYXOFIBROSARCOMAS AND UNDIFFERENTIATED PLEOMORPHIS SARCOMAS
sebastiano Calpona
Favorite
(P 533) SAFETY AND PRELIMINARY BIOLOGICAL ACTIVITY OF A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION IN SARCOMAS.
sebastiano Calpona
Favorite
Calvert, George

Norton Healthcare
(P 529) THE MUSCULOSKELETAL TUMOR REGISTRY -- 2023 UPDATE AND OUTLOOK
George Calvert
Favorite
Calvert, Paula

UHW
(P 213) EXPERIENCE WITH THE USE OF TRABECTEDIN IN ADVANCED SOFT TISSUE SARCOMA IN IRELAND
Paula Calvert
Favorite
Camacho, Luis

Center for Onc and Blood Disorders
(P 164) INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY AND IMMUNE ACTIVATION IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Luis Camacho
Favorite
Cambier, Linda

Children's Hospital Los Angeles
(P 166) SARC038: A PHASE 2 STUDY OF REGORAFENIB IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH REFRACTORY OR RECURRENT OSTEOSARCOMA
Linda Cambier
Favorite
Cam, Maren

Nationwide Children's Hospital
(P 107) TRABECTEDIN AUGMENTS ONCOLYTIC HERPES SIMPLEX VIROIMMUNOTHERAPY EFFICACY IN PRECLINCAL BONE SARCOMA MODELS THROUGH ENHANCED IMMUNE-MEDIATED MECHANISMS
Maren Cam
Favorite
Campanacci, Domenico Andrea

Department of Orthopaedic Oncology and Reconstructive Surgery, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
(P 309) CLINICAL PATHOLOGICAL CHARACTERISTICS, PATTERN OF CARE AND SURVIVAL OF NON-METASTATIC BREAST ANGIOSARCOMA
Domenico Andrea Campanacci
Favorite
(P 317) PROGNOSTIC FACTORS, CLINICAL AND TOXICITY OUTCOMES FROM A LARGE COHORT OF PATIENTS WITH SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE RADIATION THERAPY
Domenico Andrea Campanacci
Favorite
(P 455) EXTRASKELETAL EWING SARCOMA: A MULTICENTRIC RETROSPECTIVE STUDY FROM THE ITALIAN SARCOMA GROUP
Domenico Andrea Campanacci
Favorite
(P 546) PRELIMINARY CLINICAL RESULTS OF AN ONGOING PHASE II TRIAL: SPRINT (SARCOMA PREOPERATIVE RADIATION WITH SIMULTANEOUS INTEGRATED BOOST)
Domenico Andrea Campanacci
Favorite
Campbell, Matthew

UT Southwestern Medical Center
(P 542) ENROLLMENT OF PEDIATRIC PARTICIPANTS WITH MAGE-A4-POSITIVE SOLID TUMORS IN A PHASE 1/2, OPEN-LABEL, BASKET TRIAL OF AFAMITRESGENE AUTOLEUCEL ("AFAMI-CEL")
Matthew Campbell
Favorite
Campbell, Shauna

Cleveland Clinic Foundation
(P 308) OPTIMAL BIOLOGIC EFFECTIVE DOSE OF STEREOTACTIC BODY RADIOTHERAPY FOR METASTATIC AND RECURRENT SARCOMA
Shauna Campbell
Favorite
(P 514) INTERSTITIAL BRACHYTHERAPY IN THE TREATMENT OF SOFT TISSUE SARCOMA: LOCAL RECURRENCE AND WOUND OUTCOMES
Shauna Campbell
Favorite
(P 539) SARCOMA STEREOTACTIC BODY RADIOTHERAPY AND IMMUNE SYSTEM TRIAL
Shauna Campbell
Favorite
Campos, Fernando

Medical Oncology Department, A.C.Camargo Cancer Center, São Paulo, SP, Brazil
(P 189) INTERNATIONAL RETROSPECTIVE STUDY FROM THE ULTRA-RARE SARCOMA WORKING GROUP ON LOW-GRADE FIBROMYXOID SARCOMA AND SCLEROSING EPITHELIOD FIBROSARCOMA: OUTCOME OF ADVANCED DISEASE AND SYSTEMIC THERAPIES
Fernando Campos
Favorite
(P 192) ROLE OF MAGNETIC RESONANCE IMAGING IN THE PREDICTION OF HISTOLOGICAL GRADE IN SOFT TISSUE SARCOMAS.
Fernando Campos
Favorite
(P 387) CLINICAL CHARACTERIZATION OF PATIENTS WITH LEIOMYOSARCOMA HARBORING THE R337H TP53 GERMINATIVE ALTERATION (LI-FRAUMENI SYNDROME) AND THE PROGNOSTIC IMPLICATION USING A PROPENSITY-SCORE MATCHED COHORT
Fernando Campos
Favorite
Campoverde, Leticia

University of Miami
(P 158) SORAFENIB OR ANTHRACYCLINE-BASED CHEMOTHERAPY IN ADULT PATIENTS WITH PROGRESSIVE DESMOID TUMORS
Leticia Campoverde
Favorite
Cananzi, Ferdinando Carlo Maria

IRCCS Humanitas Research Hospital
(P 297) UNVEILING THE IMPACT OF INTRATUMORAL MICROBIOTA IN THE TREATMENT EFFICACY OF SOFT TISSUE SARCOMA
Ferdinando Carlo Maria Cananzi
Favorite
(P 327) LEARNING CURVE ANALYSIS IN RETROPERITONEAL SARCOMA SURGERY
Ferdinando Carlo Maria Cananzi
Favorite
(P 457) LONG-TERM FOLLOW-UP OF PATIENTS WITH ATYPICAL LIPOMATOUS TUMOR (ALT) TREATED WITH MARGINAL RESECTION IN A REFERRAL CENTER
Ferdinando Carlo Maria Cananzi
Favorite
Cannon, Matthew

Nationwide Children's Hospital
(P 107) TRABECTEDIN AUGMENTS ONCOLYTIC HERPES SIMPLEX VIROIMMUNOTHERAPY EFFICACY IN PRECLINCAL BONE SARCOMA MODELS THROUGH ENHANCED IMMUNE-MEDIATED MECHANISMS
Matthew Cannon
Favorite
(P 456) SECLIDEMSTAT TREATMENT BLOCKS THE TRANSCRIPTIONAL FUNCTION OF MULTIPLE FET-FUSION PROTEINS
Matthew Cannon
Favorite
Cano Casas, Francesc

Universitat Politècnica de Catalunya (UPC), Barcelona, Spain
(P 385) FIRST IN HUMAN PHASE I TRIAL OF A NOVEL DRUG DELIVERY IMPLANT MATRIX WITH SN-38 (CEB-01) FOR RETROPERITONEAL SOFT TISSUE SARCOMA
Francesc Cano Casas
Favorite
Cantero-Duerksen, Laura

Instituto de Previsión Social. Asunción, Paraguay
(P 142) THE SARCOMA EUROPEAN AND LATIN AMERICAN NETWORK (SELNET) PROJECT: OVERVIEW OF THE MAIN RESULTS OF THE SELNET REGISTRY
Laura Cantero-Duerksen
Favorite
Cantor, Nicole

Campbell University
(P 299) EXPLORING THE IMMUNOLIGHT MECHANISM OF ACTION IN A GENETICALLY ENGINEERED MOUSE MODEL OF SOFT TISSUE SARCOMA
Nicole Cantor
Favorite
Canyete, Adela

Pediatric Hospital La Fe
(P 212) REPORT ON THE EWING SARCOMA PATIENTS ENROLLED IN ARM D OF THE ACSE-ESMART TRIAL: PHASE I/II STUDY OF THE PARP INHIBITOR OLAPARIB IN COMBINATION WITH IRINOTECAN IN CHILDREN WITH ADVANCED MALIGNANCIES
Adela Canyete
Favorite
cao, hui

Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
(P 39) MANAGEMENT PRACTICES OF GASTROINTESTINAL STROMAL TUMORS: A QUESTIONNAIRE SURVEY OF GENERAL SURGEONS IN CHINA
hui cao
Favorite
Cao, Rui

University of Minnesota
(P 414) GENOMIC ANALYSIS OF EWING SARCOMA AND HERNIA IDENTIFIES A POSITIVE GENETIC CORRELATION AND SUGGESTS BOTH ARE LINKED TO AN HMGA2 VARIANT
Rui Cao
Favorite
Capitini, Christian

Department of Pediatrics and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health
(P 542) ENROLLMENT OF PEDIATRIC PARTICIPANTS WITH MAGE-A4-POSITIVE SOLID TUMORS IN A PHASE 1/2, OPEN-LABEL, BASKET TRIAL OF AFAMITRESGENE AUTOLEUCEL ("AFAMI-CEL")
Christian Capitini
Favorite
Capra, Michael

Children's Health Ireland (CHI)
(P 73) FOSTER CONSORTIUM, FIGHT OSTEOSARCOMA THROUGH EUROPEAN RESEARCH
Michael Capra
Favorite
Cardona, Diana

Duke University
(P 340) CENTRAL BOOST RADIATION THERAPY CAN ACHIEVE DURABLE LOCAL RESPONSE IN UNRESECTABLE RETROPERITONEAL SARCOMA
Diana Cardona
Favorite
(P 428) COMPREHENSIVE GENOMIC PROFILING OF CIC-DUX4 SARCOMA (CDS) CELL LINES AND MODELS
Diana Cardona
Favorite
Cardona, Kenneth

Department of Surgery, Winship Cancer Institute, Emory University
(P 152) EVALUATING DIAGNOSTIC APPROACHES TO DERMATOFIBROSARCOMA PROTUBERANS: AN OPPORTUNITY TO REDUCE THE NUMBER OF INTERVENTIONS
Kenneth Cardona
Favorite
(P 342) THE EVALUATION AND OUTCOMES OF MESENTERIC AND INTRA-ABDOMINAL DESMOIDS: A TARPSWG STUDY
Kenneth Cardona
Favorite
Cardwell, Maxwell

MCW
(P 473) GROIN PAINS: APPROACHES AND OUTCOMES FOR INGUINOFEMORAL SOFT TISSUE SARCOMAS
Maxwell Cardwell
Favorite
Cariboni, Umberto

Humanitas Research Hospital
(P 433) A 20-YEAR MONOCENTER EXPERIENCE ON CLINICAL CHARACTERISTICS AND OUTCOME OF EXTRASKELETAL EWING SARCOMA.
Umberto Cariboni
Favorite
Carloni, Sara

Humanitas University
(P 297) UNVEILING THE IMPACT OF INTRATUMORAL MICROBIOTA IN THE TREATMENT EFFICACY OF SOFT TISSUE SARCOMA
Sara Carloni
Favorite
Carlson, Holli

Monopar Therapeutics, Inc.
(P 184) PHASE 1B TRIAL OF CAMSIRUBICIN, A NOVEL DOXORUBICIN ANALOG, WITH CONCOMITANT PEGFILGRASTIM IN SUBJECTS WITH ADVANCED SOFT TISSUE SARCOMA TO IDENTIFY A NEW MTD/RP2D
Holli Carlson
Favorite
Carlson, Luke

University of Pittsburgh
(P 244) A DEEP FEW-SHOT META-LEARNING STRATEGY FOR AUTONOMOUS CLASSIFICATION OF BONE METASTASIS IN RADIONUCLIDE BONE SCANS
Luke Carlson
Favorite
Carney, John

Northwestern Medicine
(P 479) EXPANDABLE ENDOPROSTHESES: SHOULD WE CONSIDER NARROWING OUR INDICATIONS? A SYSTEMATIC REVIEW OF THE LITERATURE AND COMPARISON OF OUTCOMES BY AGE GROUPS
John Carney
Favorite
Caro, Claudia Haydee

The National Cancer Institute
(P 142) THE SARCOMA EUROPEAN AND LATIN AMERICAN NETWORK (SELNET) PROJECT: OVERVIEW OF THE MAIN RESULTS OF THE SELNET REGISTRY
Claudia Haydee Caro
Favorite
(P 331) MUSCULAR DEDIFFERENTIATION IN DEDIFFERENTIATED LIPOSARCOMA: INSIGHTS INTO INFLAMMATORY PROFILES USING THE NEUTROPHIL/LYMPHOCYTE RATIO AND PROGNOSTIC IMPLICATIONS
Claudia Haydee Caro
Favorite
Carpenter, Kendall

Boston Children's Hospital
(P 384) SYSTEMATIC LITERATURE AND CLINICAL TRIAL REVIEW SHOWS TARGETABLE KINASE FUSIONS ARE COMMON IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT SOFT TISSUE SARCOMAS BUT CLINICAL TRIAL OPPORTUNITIES REMAIN RARE
Kendall Carpenter
Favorite
Carrasco Garcia, Irene

Virgen del Rocio University Hospital
(P 113) IMMUNOSARC II: A SPANISH SARCOMA GROUP (GEIS) PHASE IB TRIAL OF DOXORUBICIN AND DACARBAZINE PLUS NIVOLUMAB IN FIRST LINE OF ADVANCED LEIOMYOSARCOMA
Irene Carrasco Garcia
Favorite
(P 142) THE SARCOMA EUROPEAN AND LATIN AMERICAN NETWORK (SELNET) PROJECT: OVERVIEW OF THE MAIN RESULTS OF THE SELNET REGISTRY
Irene Carrasco Garcia
Favorite
(P 453) ROLE OF SECOND-LINE TREATMENT IN EWING SARCOMAS WITH POOR PROGNOSIS AT DIAGNOSIS: EXPERIENCE OF A SPANISH REFERENCE CENTER.
Irene Carrasco Garcia
Favorite
Carrillo-Garcia, Jaime

Research Health Institute of Fundación Jiménez Díaz
(P 270) ALTERNATIVE SPLICING (AS) REGULATION AS A NOVEL THERAPEUTIC TARGET IN SOFT-TISSUE SARCOMA (STS)
Jaime Carrillo-Garcia
Favorite
Carrillo, Jaime

Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM),
(P 279) PROTEIN PHOSPHATASE 2 A INHIBITION AS A MECHANISM TO ENHANCE DOXORUBICIN ACTIVITY
Jaime Carrillo
Favorite
Caruthers, Douglas

Washington University in St Louis
(P 187) PALLIATIVE LATTICE STEREOTACTIC BODY RADIOTHERAPY FOR PATIENTS WITH SARCOMA
Douglas Caruthers
Favorite
Carvalho, Nathália

A.C.Camargo Cancer Center
(P 387) CLINICAL CHARACTERIZATION OF PATIENTS WITH LEIOMYOSARCOMA HARBORING THE R337H TP53 GERMINATIVE ALTERATION (LI-FRAUMENI SYNDROME) AND THE PROGNOSTIC IMPLICATION USING A PROPENSITY-SCORE MATCHED COHORT
Nathália Carvalho
Favorite
Casadei, Lucia

The Ohio State University Comprehensive Cancer Center
(P 335) EXTRACELLULAR VESICLE MDM2 DNA AS A BIOMARKER OF TUMOR PRESENCE AND RECURRENCE IN RETROPERITONEAL LIPOSARCOMA
Lucia Casadei
Favorite
Casadei, roberto

Orthopedic Unit, Morgagni-Pierantoni Hospital, 47121 Forli, Italy
(P 253) THE EFFICACY OF MEDICATED PATCHES IN SOFT TISSUE SARCOMAS: IN-VITRO AND EX-VIVO VALIDATION.
roberto Casadei
Favorite
(P 364) EVALUATION OF THE PREDICTIVE ROLE OF SYSTEMIC AND INTRATUMORAL IMMUNITY IN PATIENTS WITH LOCALIZED LIPOSARCOMAS, MYXOFIBROSARCOMAS AND UNDIFFERENTIATED PLEOMORPHIS SARCOMAS
roberto Casadei
Favorite
(P 533) SAFETY AND PRELIMINARY BIOLOGICAL ACTIVITY OF A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION IN SARCOMAS.
roberto Casadei
Favorite
Casado, Antonio

Hospital Universitario Clínico San Carlos
(P 149) PSYCOLOGICAL SNAPSHOT OF SARCOMA PATIENTS FROM AN ACADEMIC, UNIVERSITY CENTER, HOSPITAL CLÍNICO SAN CARLOS (HCSC), MADRID, A SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN
Antonio Casado
Favorite
(P 174) SELISARC: A SPANISH GROUP FOR RESEARCH IN SARCOMA (GEIS) PHASE I/II TRIAL OF SELINEXOR PLUS GEMCITABINE IN SELECTED SARCOMA SUBTYPES: RESULTS OF THE PHASE I PART
Antonio Casado
Favorite
(P 175) TRABECTEDIN PLUS RADIOTHERAPY ON SYMPHTOMATIC ADVANCED SARCOMA PATIENTS, RESULTS FROM THE SYNERGIAS STUDY: A SPANISH GROUP FOR RESEARCH IN SARCOMA (GEIS) PHASE II STUDY
Antonio Casado
Favorite
(P 515) ENDOBRONCHIAL NAVIGATION AS AN INTRAOPERATORY TOOL FOR RESECTION OF SMALL PULMONARY METASTASES IN SARCOMA PATIENTS
Antonio Casado
Favorite
Casali, Paolo Giovanni

Department of Medical Oncology 2, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
(P 159) IN BETWEEN OF LYMPHOMAS AND SARCOMAS: WHERE DO HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN) STAND? A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG)
Paolo Giovanni Casali
Favorite
(P 328) REAL-LIFE EXPERIENCE OF PAZOPANIB IN PATIENTS WITH ADVANCED UTERINE LEIOMYOSARCOMA (U-LMS) FROM TWO REFERRAL ITALIAN CENTERS
Paolo Giovanni Casali
Favorite
(P 333) SYSTEMIC TREATMENT IN INTRA-ABDOMINAL DESMOID-TYPE FIBROMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE CASE SERIES ANALYSIS
Paolo Giovanni Casali
Favorite
(P 378) MULTIOMICS PROFILING OF EPITHELIOID SARCOMA UNVEILS EPIGENETIC CIRCUITRIES THAT UNDERLIE THE PATHOBIOLOGY OF PROXIMAL AND CLASSIC SUBTYPES: RESULTS FROM THE ISG EPISOBS OBSERVATIONAL STUDY
Paolo Giovanni Casali
Favorite
(P 431) TREATMENT STRATEGY AND PROGNOSTIC FACTORS IN EXTRASKELETAL EWING SARCOMA: AN INSTITUTIONAL RETROSPECTIVE ANALYSIS
Paolo Giovanni Casali
Favorite
(P 455) EXTRASKELETAL EWING SARCOMA: A MULTICENTRIC RETROSPECTIVE STUDY FROM THE ITALIAN SARCOMA GROUP
Paolo Giovanni Casali
Favorite
Casanova Zaragoza, Sonia

Hospital de la Santa Creu i Sant Pau
(P 503) SCAPULAR PROSTHESIS RECONSTRUCTION, EXPERIENCE IN OUR INSTITUTION
Sonia Casanova Zaragoza
Favorite
(P 504) WHY DO SOME PATIENTS WITH SYNOVIAL SARCOMA HAVE BETTER FUNCTIONAL OUTCOMES AFTER RESECTION SURGERY? ANALYSIS OF 102 CASES
Sonia Casanova Zaragoza
Favorite
(P 508) DREAM, UTOPIA OR REALISM? PROGNOSTIC FACTORS IN LUNG METASTASECTOMY OF DISSEMINATED SARCOMA DISEASE
Sonia Casanova Zaragoza
Favorite
Casanova, Michela

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 202) INFLAMMATORY MYOFIBROBLASTIC TUMOUR WITH ROS1 GENE FUSIONS IN CHILDREN AND YOUNG ADOLESCENTS
Michela Casanova
Favorite
(P 212) REPORT ON THE EWING SARCOMA PATIENTS ENROLLED IN ARM D OF THE ACSE-ESMART TRIAL: PHASE I/II STUDY OF THE PARP INHIBITOR OLAPARIB IN COMBINATION WITH IRINOTECAN IN CHILDREN WITH ADVANCED MALIGNANCIES
Michela Casanova
Favorite
(P 273) COMPARISON OF A PATIENT-DERIVED XENOGRAFTS (PDX) OF MYXOID PLEOMORPHIC LIPOSARCOMA (MPL) AND PLEOMORPHIC LIPOSARCOMA (PL) HIGHLIGHTS THE EFFECTIVENESS OF ERIBULIN IN A PDX OF MPL
Michela Casanova
Favorite
(P 558) TRIAL IN PROGRESS: A PHASE 1/2 STUDY OF BRIGATINIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH ALK POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA OR INFLAMMATORY MYOFIBROBLASTIC TUMORS (ITCC-098)
Michela Casanova
Favorite
Cascella, Tommaso

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 14) PERCUTANEOUS CRYOABLATION OF PROGRESSING EXTRA-ABDOMINAL DESMOID TUMOURS
Tommaso Cascella
Favorite
Castaneda-Wysocka, Patricia

Maria Sklodowska-Curie National Research Institute of Oncology, Department of Radiology, Warsaw Poland
(P 310) PREOPERATIVE RADIOTHERAPY WITH HYPERTHERMIA IN RECURRENT AND RADIATION-INDUCED SARCOMAS: RESULTS OF A PHASE 2 CLINICAL TRIAL
Patricia Castaneda-Wysocka
Favorite
Castillo Orozco, Ana

Research Institute of the McGill University Health Center
(P 64) OSTEOSARCOMA. PATIENT-DERIVED XENOGRAFTS MODELS TO RECAPITULATE PATIENTS' CHEMORESISTANCE AND METASTATIC DISEASE
Ana Castillo Orozco
Favorite
(P 434) MECHANISMS OF CHEMORESISTANCE IN CIC-DUX4 SARCOMA AS DETERMINED BY IN VIVO FUNCTIONAL GENOMICS
Ana Castillo Orozco
Favorite
Castro Boix, Sandra

Servicio de Cirugía General y Digestiva, Hospitals Universitario Vall d'Hebron, Barcelona, Spain.
(P 385) FIRST IN HUMAN PHASE I TRIAL OF A NOVEL DRUG DELIVERY IMPLANT MATRIX WITH SN-38 (CEB-01) FOR RETROPERITONEAL SOFT TISSUE SARCOMA
Sandra Castro Boix
Favorite
Castro Oliden, Victor

Instituto Nacional de Enfermedades Neoplasicas
(P 142) THE SARCOMA EUROPEAN AND LATIN AMERICAN NETWORK (SELNET) PROJECT: OVERVIEW OF THE MAIN RESULTS OF THE SELNET REGISTRY
Victor Castro Oliden
Favorite
Catin, Bruna

AC Camargo Cancer Center
(P 192) ROLE OF MAGNETIC RESONANCE IMAGING IN THE PREDICTION OF HISTOLOGICAL GRADE IN SOFT TISSUE SARCOMAS.
Bruna Catin
Favorite
Catton, Charles

Princess Margaret Cancer Centre
(P 483) DID THE COVID-19 PANDEMIC NEGATIVELY AFFECT OUTCOMES FOR PATIENTS WITH EXTREMITY SOFT TISSUE SARCOMAS?
Charles Catton
Favorite
Cauchin, Estelle

ICO
(P 201) PLEOMORPHIC RHABDOMYOSARCOMAS: A NEW ENTITY ASSOCIATED WITH LYNCH SYNDROME? FIRST RESULTS OF SARCLYNCH NATIONAL STUDY
Estelle Cauchin
Favorite
Caulin, Aleah

Peel Therapeutics
(P 565) AN EARLY PHASE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF PEEL-224 IN PATIENTS WITH ADVANCED SOLID TUMORS
Aleah Caulin
Favorite
Cavaliere, Davide

General and Oncologic Surgery, "Morgagni-Pierantoni" Hospital
(P 37) DISSECTING THE ROLE OF EXTRACELLULAR VESICLES IN THE MANAGEMENT OF GIST
Davide Cavaliere
Favorite
(P 364) EVALUATION OF THE PREDICTIVE ROLE OF SYSTEMIC AND INTRATUMORAL IMMUNITY IN PATIENTS WITH LOCALIZED LIPOSARCOMAS, MYXOFIBROSARCOMAS AND UNDIFFERENTIATED PLEOMORPHIS SARCOMAS
Davide Cavaliere
Favorite
(P 533) SAFETY AND PRELIMINARY BIOLOGICAL ACTIVITY OF A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION IN SARCOMAS.
Davide Cavaliere
Favorite
Cavaliere, Silvia

Università Campus Bio-Medico di Roma
(P 263) HER2 AS A POTENTIAL NOVEL THERAPEUTIC TARGET IN SOFT TISSUE SARCOMAS
Silvia Cavaliere
Favorite
(P 264) CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS AND TRABECTEDIN IN SOFT TISSUE SARCOMA: A NOVEL POTENTIAL SYNERGY?
Silvia Cavaliere
Favorite
Cebrian, Juan Luis

Hospital Clinico San Carlos
(P 149) PSYCOLOGICAL SNAPSHOT OF SARCOMA PATIENTS FROM AN ACADEMIC, UNIVERSITY CENTER, HOSPITAL CLÍNICO SAN CARLOS (HCSC), MADRID, A SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN
Juan Luis Cebrian
Favorite
Cencelj-Arnez, Romi

Institute of Oncology Ljubljana
(P 152) EVALUATING DIAGNOSTIC APPROACHES TO DERMATOFIBROSARCOMA PROTUBERANS: AN OPPORTUNITY TO REDUCE THE NUMBER OF INTERVENTIONS
Romi Cencelj-Arnez
Favorite
Cerqueira, Wagner

AC Camargo Cancer Center
(P 192) ROLE OF MAGNETIC RESONANCE IMAGING IN THE PREDICTION OF HISTOLOGICAL GRADE IN SOFT TISSUE SARCOMAS.
Wagner Cerqueira
Favorite
chacón, Matías

Instituto Alexander Fleming
(P 142) THE SARCOMA EUROPEAN AND LATIN AMERICAN NETWORK (SELNET) PROJECT: OVERVIEW OF THE MAIN RESULTS OF THE SELNET REGISTRY
Matías chacón
Favorite
Chadha, Madhumeeta

The Institute of Cancer Research
(P 410) PROTEOMICS ANALYSIS IDENTIFIES A SIGNATURE THAT IMPROVES PROGNOSTIC RISK STRATIFICATION OF THE SARCULATOR NOMOGRAM IN PATIENTS WITH SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND TRUNK WALL
Madhumeeta Chadha
Favorite
(P 417) MULTI-OMIC CHARACTERISATION OF MOLECULAR HETEROGENEITY AND NEOADJUVANT THERAPY RESPONSE IN SYNOVIAL SARCOMAS
Madhumeeta Chadha
Favorite
CHAIRE, Vanessa

Institut Bergonié
(P 300) ANTI-TUMOR ACTIVITY OF PARP7 INHIBITOR RBN-2397 IN SOFT-TISSUE SARCOMAS
Vanessa CHAIRE
Favorite
(P 418) GENOMIC AND IMMUNOLOGICAL PROFILING OF PRIMARY AND DISTANT METASTASES OF SOFT TISSUE SARCOMAS
Vanessa CHAIRE
Favorite
Chalmers, Anna

Huntsman Cancer Institute, University of Utah
(P 135) UNMET NEEDS IN LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC DEDIFFERENTIATED LIPOSARCOMA AND EXPECTATIONS FOR CLINICAL TRIALS: AN INTERNATIONAL DELPHI CONSENSUS STUDY
Anna Chalmers
Favorite
Chan, Corey

Newcastle University
(P 228) WHAT IS THE SIGNIFICANCE OF INDETERMINATE PULMONARY NODULES IN HIGH GRADE SOFT TISSUE SARCOMA? A RETROSPECTIVE COHORT STUDY
Corey Chan
Favorite
(P 298) EVALUATING THE PHOTOTHERMAL AND CYTOTOXIC PROPERTIES OF INDOCYANINE GREEN IN VITRO FOR INTRAOPERATIVE PHOTOTHERMAL THERAPY IN SARCOMA
Corey Chan
Favorite
Chan, Corey

Northern Bone and Soft Tissue Tumour Service
(P 522) FLUORESCENCE GUIDED SURGERY WITH INDOCYANINE GREEN FOR SURGICAL RESECTION OF METASTATIC BONE AND SOFT TISSUE TUMOURS: A CASE SERIES
Corey Chan
Favorite
Chandler, Dawn

Nationwide Children's Hospital
(P 94) DEVELOPING NOVEL OLIGONUCLEOTIDE THERAPIES TO MODULATE INSULIN RECEPTOR ALTERNATIVE SPLICING IN PEDIATRIC BONE SARCOMAS
Dawn Chandler
Favorite
(P 305) A NEW MOUSE MODEL FOR TESTING SPLICE-SWITCHING THERAPIES IN RHABDOMYOSARCOMA
Dawn Chandler
Favorite
Chandran, Uma

University of Pittsburgh
(P 373) DEDIFFERENTIATED AND HIGH GRADE CHONDROSARCOMAS: HOW DOES ISOCITRATE DEHYDROGENASE STATUS APPRISE PROGNOSIS AND THERAPY?
Uma Chandran
Favorite
Chang, Alexander

University of Pittsburgh
(P 373) DEDIFFERENTIATED AND HIGH GRADE CHONDROSARCOMAS: HOW DOES ISOCITRATE DEHYDROGENASE STATUS APPRISE PROGNOSIS AND THERAPY?
Alexander Chang
Favorite
Chang, John

ProCure
(P 320) A PROSPECTIVE MULTICENTER EXPERIENCE OF PROTON THERAPY FOR RHABDOMYOSARCOMA AND EWING SARCOMA: OUTCOMES FROM THE PROTON COLLABORATIVE GROUP REGISTRY
John Chang
Favorite
Chang, Yu-Hui

Mayo Clinic Arizona
(P 141) TREATMENT VARIABILITY IN SURGICAL MANAGEMENT OF PULMONARY OLIGOMETASTATIC SOFT TISSUE SARCOMA
Yu-Hui Chang
Favorite
Chan, Jason

Memorial Sloan Kettering Cancer Center
(P 24) COMPREHENSIVE ANALYSIS OF THE GENOMIC LANDSCAPE AND CLINICAL BEHAVIOR IN GIST USING NEXT GENERATION SEQUENCING (NGS, MSK-IMPACT)
Jason Chan
Favorite
(P 257) CHARACTERIZING THE EVOLUTION AND THERAPEUTIC RESPONSE OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS USING MOUSE MODELS
Jason Chan
Favorite
Chan, Jason Yongsheng

National Cancer Centre Singapore
(P 285) TUMOUR-INFILTRATING MAST CELLS IN ANGIOSARCOMAS CORRELATE WITH CLINCIAL PHENOTYPES AND IMMUNO-ONCOLOGY PATHWAYS
Jason Yongsheng Chan
Favorite
Chan, Jennifer

University of Calgary
(P 110) GCAR1: GPNMB CAR T THERAPY FOR MIT FAMILY TRANSLOCATION POSITIVE CANCERS
Jennifer Chan
Favorite
Chan, Marina

Fred Hutchinson Cancer Center
(P 447) TARGETING FOCAL ADHESION KINASE AUGMENTS THE THERAPEUTIC POTENTIAL OF BROMODOMAIN INHIBITORS IN EWING SARCOMA
Marina Chan
Favorite
Chan, Timothy

Cleveland Clinic
(P 429) SARCOMA FUSION GENE ANALYSIS YIELDS PROMISING HLA ANTIGEN FIT IN EWING SARCOMA AND DESMOPLASTIC SMALL ROUND CELL TUMOR
Timothy Chan
Favorite
(P 539) SARCOMA STEREOTACTIC BODY RADIOTHERAPY AND IMMUNE SYSTEM TRIAL
Timothy Chan
Favorite
Chapela, Jorge

University of Buenos Aires, Angel H Roffo Institute of Oncology
(P 460) IMPACT OF RESIDUAL TUMOR AFTER RE-EXCISION IN PATIENTS WITH PRIOR UNPLANNED RESECTION OF EXTREMITY AND TRUNK SOFT TISSUE SARCOMAS
Jorge Chapela
Favorite
Charlson, John

Medical College of Wisconsin
(P 114) PRIMARY ANALYSIS OF EFFICACY AND SAFETY OF LETETRESGENE AUTOLEUCEL (LETE-CEL) AS FIRST-LINE TREATMENT FOR UNRESECTABLE OR METASTATIC SYNOVIAL SARCOMA (SS); SUBSTUDY 1 OF IGNYTE-ESO
John Charlson
Favorite
(P 180) HEALTH RELATED QUALITY OF LIFE OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA AND OTHER SOFT TISSUE SARCOMAS TREATED WITH CABOZANTINIB AND TEMOZOLOMIDE
John Charlson
Favorite
(P 181) REAL-WORLD EXPERIENCE WITH LIPOSOMAL DOXORUBICIN IN METASTATIC AND LOCALLY ADVANCED SARCOMA
John Charlson
Favorite
(P 346) DETECTION OF GERMLINE VARIANTS IN PATIENTS DIAGNOSED WITH SOFT TISSUE SARCOMA USING EXPANDED
John Charlson
Favorite
(P 473) GROIN PAINS: APPROACHES AND OUTCOMES FOR INGUINOFEMORAL SOFT TISSUE SARCOMAS
John Charlson
Favorite
Chatziantoniou, Cyrano

Image Sciences Institute, UMC utrecht
(P 229) ON THE VARIABILITY IN THE ANALYSIS OF APPARENT DIFFUSION COEFFICIENT ESTIMATES FOR MULTICENTER DIFFUSION MRI DATA OF RHABDOMYOSARCOMA PATIENTS
Cyrano Chatziantoniou
Favorite
Chau, Bonny

University of Washington
(P 177) ANGIOSARCOMA: AN INCREASING PROBLEM IN THE UNITED STATES
Bonny Chau
Favorite
Chaudhuri, Aadel

Washington University in St Louis
(P 187) PALLIATIVE LATTICE STEREOTACTIC BODY RADIOTHERAPY FOR PATIENTS WITH SARCOMA
Aadel Chaudhuri
Favorite
Chavarria Murillo, Sonia Stephania

Hospital de la Santa Creu i Sant Pau
(P 507) PRIMARY CHEST WALL TUMORS OF MESENCHYMAL ORIGIN. EXPERIENCE OF A REFERENCE UNIT
Sonia Stephania Chavarria Murillo
Favorite
(P 508) DREAM, UTOPIA OR REALISM? PROGNOSTIC FACTORS IN LUNG METASTASECTOMY OF DISSEMINATED SARCOMA DISEASE
Sonia Stephania Chavarria Murillo
Favorite
Chawla, Akhil

Northwestern Memorial Hospital
(P 219) ELECTIVE DISCONTINUATION OF SORAFENIB TREATMENT IN DESMOID TUMORS: A RETROSPECTIVE ANALYSIS WITH IMPLICATIONS FOR CLINICAL PRACTICE
Akhil Chawla
Favorite
Chawla, Neal

Sarcoma Oncology Center
(P 116) UPDATE ON SAINT: RESULTS OF 100 PATIENTS TREATED WITH IPILIMUMAB (I), NIVOLUMAB (N) AND TRABECTEDIN (T) AS FIRST LINE THERAPY FOR ADVANCED SOFT TISSUE SARCOMA [NCT03138161]
Neal Chawla
Favorite
(P 117) INTERIM ANALYSIS OF PHASE 2 STUDY: A METRONOMIC REGIMEN USING GEMCITABINE, DOXORUBICIN, DOCETAXEL AND NIVOLUMAB FOR ADVANCED LEIOMYOSARCOMA (NCT04535713)
Neal Chawla
Favorite
(P 553) A PHASE 1/2A OPEN-LABEL, DOSE-ESCALATION/DOSE EXPANSION SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDY OF IMX-110 IN PATIENTS WITH ADVANCED SOLID TUMORS
Neal Chawla
Favorite
Chawla, Sant

Sarcoma Oncology Center
(P 111) INTERIM ANALYSIS OF A PHASE 1 STUDY USING IL12-FHAB WITH OPTIMIZED PHARMACOKINETICS
Sant Chawla
Favorite
(P 112) PHASE 1/2 STUDY OF YH001, A CTLA-4 ANTIBODY WITH THE SUBCUTANEOUSLY ADMINISTERED PD-L1 ANTIBODY ENVAFOLIMAB, WITH OR WITHOUT DOXORUBICIN IN PATIENTS WITH ADVANCED OR METASTATIC SOFT TISSUE SARCOMA
Sant Chawla
Favorite
(P 116) UPDATE ON SAINT: RESULTS OF 100 PATIENTS TREATED WITH IPILIMUMAB (I), NIVOLUMAB (N) AND TRABECTEDIN (T) AS FIRST LINE THERAPY FOR ADVANCED SOFT TISSUE SARCOMA [NCT03138161]
Sant Chawla
Favorite
(P 117) INTERIM ANALYSIS OF PHASE 2 STUDY: A METRONOMIC REGIMEN USING GEMCITABINE, DOXORUBICIN, DOCETAXEL AND NIVOLUMAB FOR ADVANCED LEIOMYOSARCOMA (NCT04535713)
Sant Chawla
Favorite
(P 178) INITIAL RESULTS FROM A PHASE 1 STUDY OF CFT8634, A NOVEL BIFUCTIONAL DEGRADATION ACTIVATING COMPOUND (BIDAC) DEGRADER OF BRD9, IN SYNOVIAL SARCOMA AND SMARCB1-NULL TUMORS
Sant Chawla
Favorite
(P 183) A PHASE 1B/2 STUDY OF LIPOSOMAL ANNAMYCIN (ANN) IN SUBJECTS WITH PREVIOUSLY TREATED SOFT-TISSUE SARCOMAS (STS) WITH PULMONARY METASTASES
Sant Chawla
Favorite
(P 184) PHASE 1B TRIAL OF CAMSIRUBICIN, A NOVEL DOXORUBICIN ANALOG, WITH CONCOMITANT PEGFILGRASTIM IN SUBJECTS WITH ADVANCED SOFT TISSUE SARCOMA TO IDENTIFY A NEW MTD/RP2D
Sant Chawla
Favorite
(P 185) LONGITUDINAL MUTATIONAL ANALYSIS OF TP53 IN CIRCULATING TUMOR DNA IN THE PLASMA OF PATIENTS WITH LIPOSARCOMA IN A PHASE I STUDY OF BRIGIMADLIN (BI 907828), AN MDM2-P53 ANTAGONIST
Sant Chawla
Favorite
(P 383) AI ANALYSIS SHOWS ENHANCED CCNG1 ONCOGENE EXPRESSION IN SARCOMA TUMORS AND SUPPORTS THE USE OF DELTAREX-G, A CCNG1 INHIBITOR, AS PLATFORM THERAPY FOR ADVANCED SARCOMA
Sant Chawla
Favorite
(P 439) THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 COMBINED WITH CHEMOTHERAPY IN EWING SARCOMA: PRELIMINARY DATA FROM A PHASE 1 STUDY
Sant Chawla
Favorite
(P 531) ENVASARC: A PIVOTAL TRIAL OF ENVAFOLIMAB AND ENVAFOLIMAB IN COMBINATION WITH IPILIMUMAB IN PATIENTS WITH ADVANCED OR METASTATIC UPS OR MFS WHO HAVE PROGRESSED ON PRIOR CHEMOTHERAPY
Sant Chawla
Favorite
(P 548) A PHASE 2/3 STUDY EVALUATING THE EFFICACY AND SAFETY OF UNESBULIN IN ADVANCED LEIOMYOSARCOMA (SUNRISELMS)
Sant Chawla
Favorite
(P 553) A PHASE 1/2A OPEN-LABEL, DOSE-ESCALATION/DOSE EXPANSION SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDY OF IMX-110 IN PATIENTS WITH ADVANCED SOLID TUMORS
Sant Chawla
Favorite
Checco, Martina Angela

Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Laboratorio di Controllo di Prodotti Biologici, Centro di Referenza Nazionale per i Metodi Alternativi, Benessere e Cura degli Animali da Laboratorio
(P 283) A TRIDIMENSIONAL PRECLINICAL MODEL TO STUDY HUMAN AND CANINE OSTEOSARCOMA DEVELOPMENT AND INTERACTION WITH TUMOR MICROENVIRONMENT
Martina Angela Checco
Favorite
Chellappa, Venkatesh

Karolinska institutet
(P 243) EVALUATION OF THE USE OF WGS IN ROUTINE DIAGNOSTICS FOR BONE AND SOFT TISSUE TUMORS
Venkatesh Chellappa
Favorite
Chen, Andrew

Ottawa Hospital Research Institute
(P 98) TUMOR IMMUNE PROFILING AND IDENTIFICATION OF IMMUNOTHERAPEUTIC TARGETS IN DEDIFFERENTIATED LIPOSARCOMA
Andrew Chen
Favorite
Chen, Bo

Department of Osteopathic Oncology, Honghui Hospital, Xi'an Jiaotong University
(P 169) UPDATED EFFICACY AND SAFETY PROFILE OF PIMICOTINIB (ABSK021) IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): 1-YEAR FOLLOW-UP FROM PHASE 1B
Bo Chen
Favorite
Chen, Chun-Yu

Nationwide Children's Hospital
(P 107) TRABECTEDIN AUGMENTS ONCOLYTIC HERPES SIMPLEX VIROIMMUNOTHERAPY EFFICACY IN PRECLINCAL BONE SARCOMA MODELS THROUGH ENHANCED IMMUNE-MEDIATED MECHANISMS
Chun-Yu Chen
Favorite
(P 125) MYELOMODULATORY TREATMENTS AUGMENT THE THERAPEUTIC BENEFIT OF ONCOLYTIC VIRUS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS BY MODULATING THE TUMOR MICROENVIRONMENT
Chun-Yu Chen
Favorite
Chen, Eleanor

University of Washington
(P 67) GENOMIC CHARACTERIZATION OF CHONDROSARCOMA: A RARE SARCOMA WITH CLINICAL RESPONSES TO IMMUNE CHECKPOINT INHIBITION
Eleanor Chen
Favorite
(P 206) A SINGLE-ARM, PHASE II STUDY OF NEOADJUVANT PEMBROLIZUMAB COMBINED WITH RADIOTHERAPY IN THE PRIMARY TREATMENT OF SOFT TISSUE SARCOMAS.
Eleanor Chen
Favorite
Cheng, Ann-Lii

National Taiwan University Hospital
(P 350) LIVER ANGIOSARCOMA IS ASSOCIATED WITH ARISTOLOCHIC ACID EXPOSURE AND HAS A DISTINCT TELOMERE MAINTENANCE MECHANISM
Ann-Lii Cheng
Favorite
Cheng, Donghang

MD Anderson Cancer Center
(P 101) EPIGENETIC MODULATION OF NK CELLS IMPROVES TUMOR TRAFFICKING AND ENHANCES THERAPEUTIC EFFICACY AGAINST OSTEOSARCOMA
Donghang Cheng
Favorite
Cheng, Edward

University of Minnesota
(P 167) FDG-PET-CT RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY PREDICTS LONG-TERM OUTCOME IN PATIENTS WITH SOFT TISSUE SARCOMA -- 15-YEAR FOLLOW-UP
Edward Cheng
Favorite
Cheng, Yuwei

Division of Biostatistics and Bioinformatics, Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego
(P 28) RETROSPECTIVE ANALYSIS OF SUCCINATE DEHYDROGENASE (SDH)-DEFICIENT GASTROINTESTINAL STROMAL TUMOR (GIST) OUTCOMES: AN INTERNATIONAL STUDY OF 256 PATIENTS
Yuwei Cheng
Favorite
Chen, Hao

Johns Hopkins University School of Medicine
(P 559) PROSPECTIVE PHASE II TRIAL OF PREOPERATIVE HYPOFRACTIONATED PROTON THERAPY FOR EXTREMITY AND TRUNCAL AND TRUNCAL SOFT TISSUE SARCOMA: THE PRONTO STUDY RATIONALE AND DESIGN
Hao Chen
Favorite
Chen, James

The Ohio State University
(P 452) SECONDARY GENOMIC LANDSCAPE OF CIC::DUX4 FUSION SARCOMAS
James Chen
Favorite
Chen, Jenny

Levine Cancer Institute
(P 258) THE CRITICALITY OF OXIDATIVE PHOSPHORYLATION IN SYNOVIAL SARCOMA METASTASIS
Jenny Chen
Favorite
Chen, Jia

Department of Oncology, Jiangsu Cancer Hospital
(P 44) RIPRETINIB FOR THE TREATMENT OF CHINESE PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS HARBORING KIT SECONDARY MUTATIONS: A MULTICENTER, RETROSPECTIVE STUDY
Jia Chen
Favorite
(P 48) SIGNIFICANCE OF MONITORING PLASMA CONCENTRATION OF RIPRETINIB IN CHINESE PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS
Jia Chen
Favorite
chen, jiansi

Department of Medical Image Center, Affiliated Tumor Hospital of Guangxi Medical University
(P 39) MANAGEMENT PRACTICES OF GASTROINTESTINAL STROMAL TUMORS: A QUESTIONNAIRE SURVEY OF GENERAL SURGEONS IN CHINA
jiansi chen
Favorite
Chen, Jun

Retroperitoneal Tumours Centre, Peking University International Hospital, Beijing, China
(P 398) INTEGRATED MULTI-OMICS APPROACH REVEALED TUMOR-ASSOCIATED TERTIARY LYMPHOID STRUCTURE LANDSCAPE IN RETROPERITONEAL LIPOSARCOMA
Jun Chen
Favorite
(P 534) NEOADJUVANT CHEMOTHERAPY COMBINED WITH TARGETED TREATMENT IN HIGH-RISK RETROPERITONEAL SARCOMA – A PROSPECTIVE NON-RANDOMIZED CONTROLLED MULTI-CENTERED STUDY ALL ACROSS CHINA
Jun Chen
Favorite
Chen, Sonja

Nationwide Children's Hospital/The Ohio State University College of Medicine
(P 409) IMMUNOHISTOCHEMICAL STAINING FOR MYOGENIN, AP2 BETA AND HMGA2 PREDICT FOXO1 FUSION STATUS IN RHABDOMYOSARCOMA: A REPORT FROM THE SOFT TISSUE COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Sonja Chen
Favorite
(P 425) CHARACTERIZATION OF RHABDOMYOSARCOMA WITH PAX7::FOXO1 FUSIONS: A REPORT FROM THE SOFT TISSUE COMMITTEE OF THE CHILDREN'S ONCOLOGY GROUP
Sonja Chen
Favorite
(P 438) ALVEOLAR RHABDOMYOSARCOMA WITH "BURKITT-LIKE" MORPHOLOGY IS ASSOCIATED WITH HIGH AMPLIFICATION OF MYCL
Sonja Chen
Favorite
Chen, Tom Wei-Wu

National Taiwan University Hospital
(P 139) ULTRA-RARE SARCOMAS HAVE WORSE SURVIVAL COMPARED TO NON-ULTRA-RARE SARCOMAS: A NATIONAL CANCER REGISTRY STUDY
Tom Wei-Wu Chen
Favorite
(P 168) A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEXIDARTINIB IN ASIAN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR
Tom Wei-Wu Chen
Favorite
(P 350) LIVER ANGIOSARCOMA IS ASSOCIATED WITH ARISTOLOCHIC ACID EXPOSURE AND HAS A DISTINCT TELOMERE MAINTENANCE MECHANISM
Tom Wei-Wu Chen
Favorite
(P 399) CRITICAL MOLECULAR PATHWAYS ASSOCIATED WITH DIFFERENT HISTOPATHOLOGY FEATURES AND DETAILED PATTERNS OF IMMUNE CELL INFILTRATES IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Tom Wei-Wu Chen
Favorite
Chen, Weida

Department of Retroperitoneal Tumor Surgery, Peking University International Hospital
(P 534) NEOADJUVANT CHEMOTHERAPY COMBINED WITH TARGETED TREATMENT IN HIGH-RISK RETROPERITONEAL SARCOMA – A PROSPECTIVE NON-RANDOMIZED CONTROLLED MULTI-CENTERED STUDY ALL ACROSS CHINA
Weida Chen
Favorite
Chen, Yen-Lin

Massachusetts General Hospital
(P 338) PREOPERATIVE RADIATION THERAPY IS NOT ASSOCIATED WITH ADVERSE POSTOPERATIVE OUTCOMES IN PATIENTS WITH RETROPERITONEAL SARCOMA
Yen-Lin Chen
Favorite
Chen, Zebin

The First Affiliated Hospital of Sun Yat-sen University
(P 45) THE LONG-TERM EFFECT OF IMATINIB WITH HEPATIC RESECTION OR OTHER LOCAL TREATMENT FOR GIST LIVER METASTASES
Zebin Chen
Favorite
Cheung, Kingsley

Prince of Wales Hospital, Hong Kong
(P 290) PRE-CLINICAL STUDY OF TUMOR TREATING FIELDS (TTFIELDS) ALONE OR IN CONJUNCTION WITH SYSTEMIC THERAPIES IN SELECTED BONE- AND SOFT-TISSUE SARCOMAS
Kingsley Cheung
Favorite
Cheung, Phyllis

Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen
(P 248) FIBROBLAST ACTIVATION PROTEIN ALPHA -DIRECTED IMAGING AND THERAPY OF SOLITARY FIBROUS TUMOR
Phyllis Cheung
Favorite
Chia, Claramae

Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT), Division of Surgery and Surgical Oncology, National Cancer Centre Singapore
(P 336) EVOLUTION AND PURSUIT OF EXCELLENCE IN SARCOMA MANAGEMENT IN AN ASIAN TERTIARY SARCOMA SPECIALISED CENTRE
Claramae Chia
Favorite
Chiang, Ruru Chun-Ju

National Taiwan University
(P 139) ULTRA-RARE SARCOMAS HAVE WORSE SURVIVAL COMPARED TO NON-ULTRA-RARE SARCOMAS: A NATIONAL CANCER REGISTRY STUDY
Ruru Chun-Ju Chiang
Favorite
Chiarappa, Frank

University of California San Diego
(P 489) SIMULTANEOUS VERSUS DELAYED FLAP RECONSTRUCTION FOLLOWING SOFT TISSUE SARCOMA RESECTION
Frank Chiarappa
Favorite
(P 490) TOPICAL ANTIBIOTICS DECREASE INFECTIONS IN EXTREMITY SARCOMA SURGERY
Frank Chiarappa
Favorite
Chibon, Frederic

Cancer Research Center of Toulouse
(P 104) COMPREHENSIVE IMMUNE PROFILING UNVEILS A SUBSET OF LEIOMYOSARCOMA WITH HOT TUMOR IMMUNE MICROENVIRONMENT
Frederic Chibon
Favorite
(P 201) PLEOMORPHIC RHABDOMYOSARCOMAS: A NEW ENTITY ASSOCIATED WITH LYNCH SYNDROME? FIRST RESULTS OF SARCLYNCH NATIONAL STUDY
Frederic Chibon
Favorite
(P 268) IMPACT OF CELLULAR FUSION IN THE ONCOGENESIS OF LEIOMYOSARCOMAS
Frederic Chibon
Favorite
Chidiac, Charbel

The Johns Hopkins Hospital
(P 143) EXPLORING HOSPITAL VOLUME THRESHOLDS FOR IMPROVED SARCOMA TREATMENT ACROSS DIFFERENT AGE CATEGORIES IN THE UNITED STATES
Charbel Chidiac
Favorite
Chin Chang, Yen

University College Hospitals London
(P 321) IDENTIFYING RISK FACTORS FOR REDUCTION OF PROTON THERAPY RE-PLANS FOR PAEDIATRIC PATIENTS WITH PELVIC SARCOMAS
Yen Chin Chang
Favorite
Chi, Ping

Memorial Sloan Kettering Cancer Center
(P 24) COMPREHENSIVE ANALYSIS OF THE GENOMIC LANDSCAPE AND CLINICAL BEHAVIOR IN GIST USING NEXT GENERATION SEQUENCING (NGS, MSK-IMPACT)
Ping Chi
Favorite
Chisholm, Julia

Children and Young Peoples Unit, Royal Marsden Hospital and Institute of Cancer Research
(P 209) PROGNOSTIC VALUE OF EARLY RADIOLOGIC TUMOUR VOLUME RESPONSE IN RHABDOMYOSARCOMA; RESULTS OF THE EUROPEAN PAEDIATRIC SOFT TISSUE SARCOMA STUDY GROUP RMS 2005 STUDY
Julia Chisholm
Favorite
Chitalia, Rhea

Invicro
(P 408) CHANGES IN COMPUTED TOMOGRAPHY FEATURES INDUCED BY BRIGIMADLIN (BI 907828) IN PATIENTS WITH LIPOSARCOMA: INSIGHTS FROM PHASE I STUDIES
Rhea Chitalia
Favorite
Chitalkar, Prakash

Sri Aurobindo Institute of Medical Sciences, Indore, India
(P 06) ONCOFERTILITY AND PREGNANCY IN ADOLESCENT AND YOUNG ADULT CANCERS: PHYSICIANS' KNOWLEDGE AND PREFERENCES IN A LARGE LOW-MIDDLE- INCOME COUNTRY
Prakash Chitalkar
Favorite
Chiusole, Benedetta

Oncology 1 Unit, Department of Oncology, Veneto Institute of Oncology IOV - IRCCS
(P 171) SEX DIFFERENCES IN OUTCOMES AND TOXICITY IN PATIENTS TREATED FOR SARCOMA IN A REFERENCE CENTER
Benedetta Chiusole
Favorite
(P 216) BRAIN METASTASES IN SARCOMA: A (NOT SO) RARE EVENT. THE EXPERIENCE OF A HIGH VOLUME CENTER
Benedetta Chiusole
Favorite
(P 455) EXTRASKELETAL EWING SARCOMA: A MULTICENTRIC RETROSPECTIVE STUDY FROM THE ITALIAN SARCOMA GROUP
Benedetta Chiusole
Favorite
Chi, Yueh-Yun

Children's Hospital Los Angeles
(P 430) UNIQUE HISTOLOGIC MORPHOLOGY OF EWING SARCOMA CELLS THAT HARBOR TP53 MUTATIONS
Yueh-Yun Chi
Favorite
Cho, Haeun

Korea Institute of Radiation and Medical Sciences
(P 281) FIVE DAY SPACING OF TWO FRACTIONATED ABLATIVE RADIOTHERAPIES ENHANCES ANTITUMOR IMMUNITY IN FIBROSARCOMA CELL LINE
Haeun Cho
Favorite
Cho, L. Chinsoo

University of Minnesota
(P 167) FDG-PET-CT RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY PREDICTS LONG-TERM OUTCOME IN PATIENTS WITH SOFT TISSUE SARCOMA -- 15-YEAR FOLLOW-UP
L. Chinsoo Cho
Favorite
Chong, Clara

Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore
(P 336) EVOLUTION AND PURSUIT OF EXCELLENCE IN SARCOMA MANAGEMENT IN AN ASIAN TERTIARY SARCOMA SPECIALISED CENTRE
Clara Chong
Favorite
Chorny, Michael

University of Pennsylvania Perelman School of Medicine; Children's Hospital of Philadelphia
(P 565) AN EARLY PHASE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF PEEL-224 IN PATIENTS WITH ADVANCED SOLID TUMORS
Michael Chorny
Favorite
Cho, Sukjoo

Department of Pediatrics, University of South Florida Morsani College of Medicine
(P 91) BLOOD TRANSFUSION AND SURVIVAL AMONG CHILD, ADOLESCENT, AND YOUNG ADULT PATIENTS WITH OSTEOSARCOMA: A RETROSPECTIVE COHORT STUDY
Sukjoo Cho
Favorite
Cho, Sunny

SpringWorks Therapeutics Inc
(P 188) IMPACT OF NIROGACESTAT ON FUNCTIONAL STATUS IN PATIENTS WITH DESMOID TUMORS: RESULTS FROM THE PHASE 3 DEFI STUDY
Sunny Cho
Favorite
Chow, Warren

University of California, Irvine
(P 326) MOLECULAR LANDSCAPE OF ENDOMETRIAL STROMAL SARCOMA IN A LARGE REAL-WORLD PATIENT COHORT
Warren Chow
Favorite
Choy, Edwin

Mass General Cancer Center
(P 172) PHASE 2 RESULTS FROM THE RINGSIDE PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS
Edwin Choy
Favorite
(P 338) PREOPERATIVE RADIATION THERAPY IS NOT ASSOCIATED WITH ADVERSE POSTOPERATIVE OUTCOMES IN PATIENTS WITH RETROPERITONEAL SARCOMA
Edwin Choy
Favorite
Christensen, Anthony

St. Jude Children's Research Hospital
(P 528) SAFETY AND TOLERABILITY OF ORAL CYCLOPHOSPHAMIDE AND SORAFENIB WITH INTRAVENOUS BEVACIZUMAB WITH THE ADDITION OF ATEZOLIZUMAB IN PEDIATRIC SOLID TUMOR PATIENTS
Anthony Christensen
Favorite
Christensen, Stine

Copenhagen University Hospital at Herlev, Denmark
(P 157) QUALITY OF LIFE DURING TREATMENT FOR METASTATIC SARCOMA - FEASIBILITY OF ELECTRONIC PATIENT REPORTED OUTCOMES
Stine Christensen
Favorite
Christo, Jessica

IDRx, Inc
(P 26) PHASE 1 STUDY OF IDRX-42 IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS RESISTANT TO PRIOR SYSTEMIC THERAPY: EARLY RESULTS
Jessica Christo
Favorite
Chua, Victoria

Sarcoma Oncology Center
(P 111) INTERIM ANALYSIS OF A PHASE 1 STUDY USING IL12-FHAB WITH OPTIMIZED PHARMACOKINETICS
Victoria Chua
Favorite
(P 116) UPDATE ON SAINT: RESULTS OF 100 PATIENTS TREATED WITH IPILIMUMAB (I), NIVOLUMAB (N) AND TRABECTEDIN (T) AS FIRST LINE THERAPY FOR ADVANCED SOFT TISSUE SARCOMA [NCT03138161]
Victoria Chua
Favorite
(P 117) INTERIM ANALYSIS OF PHASE 2 STUDY: A METRONOMIC REGIMEN USING GEMCITABINE, DOXORUBICIN, DOCETAXEL AND NIVOLUMAB FOR ADVANCED LEIOMYOSARCOMA (NCT04535713)
Victoria Chua
Favorite
(P 184) PHASE 1B TRIAL OF CAMSIRUBICIN, A NOVEL DOXORUBICIN ANALOG, WITH CONCOMITANT PEGFILGRASTIM IN SUBJECTS WITH ADVANCED SOFT TISSUE SARCOMA TO IDENTIFY A NEW MTD/RP2D
Victoria Chua
Favorite
(P 553) A PHASE 1/2A OPEN-LABEL, DOSE-ESCALATION/DOSE EXPANSION SAFETY, TOLERABILITY AND PHARMACOKINETIC STUDY OF IMX-110 IN PATIENTS WITH ADVANCED SOLID TUMORS
Victoria Chua
Favorite
Chudasama, Priya

Precision Sarcoma Research Group, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg
(P 124) UNLOCKING THE POTENTIAL OF MEASLES VIRUS ONCOLYTIC IMMUNOTHERAPY FOR SARCOMA: BIOMARKER DISCOVERY AND THERAPEUTIC VACCINE DEVELOPMENT
Priya Chudasama
Favorite
Chugh, Rashmi

University of Michigan Rogel Cancer Center
(P 07) IDENTIFYING CONCERNS OF ADOLESCENT AND YOUNG ADULT SARCOMA PATIENTS AND SURVIVORS FOLLOWING FERTIITY PRESERVATION
Rashmi Chugh
Favorite
(P 172) PHASE 2 RESULTS FROM THE RINGSIDE PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS
Rashmi Chugh
Favorite
(P 188) IMPACT OF NIROGACESTAT ON FUNCTIONAL STATUS IN PATIENTS WITH DESMOID TUMORS: RESULTS FROM THE PHASE 3 DEFI STUDY
Rashmi Chugh
Favorite
(P 293) GENERATION OF A SPONTANEOUS IMMUNOCOMPETENT MOUSE MODEL OF LIPOSARCOMA
Rashmi Chugh
Favorite
(P 439) THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 COMBINED WITH CHEMOTHERAPY IN EWING SARCOMA: PRELIMINARY DATA FROM A PHASE 1 STUDY
Rashmi Chugh
Favorite
(P 449) CIC-DUX4 sarcomas: A single-center review of clinical features and molecular aberrations identified through DNA sequencing
Rashmi Chugh
Favorite
(P 548) A PHASE 2/3 STUDY EVALUATING THE EFFICACY AND SAFETY OF UNESBULIN IN ADVANCED LEIOMYOSARCOMA (SUNRISELMS)
Rashmi Chugh
Favorite
Chuleerarux, Nipat

University of Miami
(P 158) SORAFENIB OR ANTHRACYCLINE-BASED CHEMOTHERAPY IN ADULT PATIENTS WITH PROGRESSIVE DESMOID TUMORS
Nipat Chuleerarux
Favorite
Chun, Danielle

Southern California Permanente Group
(P 474) PREDICTORS OF EARLY INTROWTH AND FAILURE FOLLOWING SHORT COMPRESS SPINDLE OSSEOINTEGRATION FIXATION AT THE LOWER EXTREMITIES
Danielle Chun
Favorite
Chung, Elaine

Kaiser Permanente
(P 224) CO-MUTATION-DEPENDENT PROGNOSIS IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA
Elaine Chung
Favorite
Chung, Peter

Princess Margaret Cancer Centre
(P 367) CHARACTERIZING HYPOXIA AND ASSOCIATED MOLECULAR FEATURES IN EXTREMITY SOFT TISSUE SARCOMA
Peter Chung
Favorite
(P 483) DID THE COVID-19 PANDEMIC NEGATIVELY AFFECT OUTCOMES FOR PATIENTS WITH EXTREMITY SOFT TISSUE SARCOMAS?
Peter Chung
Favorite
Chun, Liane

University of California San Diego
(P 489) SIMULTANEOUS VERSUS DELAYED FLAP RECONSTRUCTION FOLLOWING SOFT TISSUE SARCOMA RESECTION
Liane Chun
Favorite
Chu, Randy

MD Anderson Cancer Center
(P 394) LEIOMYOSARCOMA INTRATUMORAL MACROPHAGE INFILTRATES ARE ASSOCIATED WITH DISTINCT CLINICAL AND GENOMIC PRESENTATIONS
Randy Chu
Favorite
Church, Alanna

Dana-Farber/Boston Children's Cancer and Blood Disorders Center
(P 03) EVOLUTION OF CLINICALLY ACTIONABLE VARIANTS IN ADVANCED PEDIATRIC AND AYA BONE SARCOMAS
Alanna Church
Favorite
Cicala, Carlo

Vall d'Hebron Institute of Oncology
(P 326) MOLECULAR LANDSCAPE OF ENDOMETRIAL STROMAL SARCOMA IN A LARGE REAL-WORLD PATIENT COHORT
Carlo Cicala
Favorite
Cingarlini, Sara

University of Verona
(P 272) A COMPARATIVE ASSESSMENT OF SELINEXOR WITH TRABECTEDIN OR LURBINECTEDIN IN PATIENT-DERIVED XENOGRAFTS (PDX) OF DEDIFFERENTIATED LIPOSARCOMA (DDLPS)
Sara Cingarlini
Favorite
Cini, John

Sonnet BioTherapeutics
(P 111) INTERIM ANALYSIS OF A PHASE 1 STUDY USING IL12-FHAB WITH OPTIMIZED PHARMACOKINETICS
John Cini
Favorite
Civantos, Gonzalo

Hospital Clínico San Carlos
(P 515) ENDOBRONCHIAL NAVIGATION AS AN INTRAOPERATORY TOOL FOR RESECTION OF SMALL PULMONARY METASTASES IN SARCOMA PATIENTS
Gonzalo Civantos
Favorite
Clarke, Callisia

Medical College Of Wisconsin - Surgical Oncology
(P 181) REAL-WORLD EXPERIENCE WITH LIPOSOMAL DOXORUBICIN IN METASTATIC AND LOCALLY ADVANCED SARCOMA
Callisia Clarke
Favorite
(P 346) DETECTION OF GERMLINE VARIANTS IN PATIENTS DIAGNOSED WITH SOFT TISSUE SARCOMA USING EXPANDED
Callisia Clarke
Favorite
(P 473) GROIN PAINS: APPROACHES AND OUTCOMES FOR INGUINOFEMORAL SOFT TISSUE SARCOMAS
Callisia Clarke
Favorite
Clarkson, Paul

British Columbia Children's Hospital
(P 512) PERIOPERATIVE BLOOD MANAGEMENT IN PEDIATRIC PATIENTS UNDERGOING PRIMARY OSTEOSARCOMA AND EWING SARCOMA RESECTION: A RETROSPECTIVE CASE NOTE REVIEW
Paul Clarkson
Favorite
Claude, Line

Leon Berard Center
(P 69) DEVELOPMENT AND MISSION OF THE HARMONIZATION INTERNATIONAL BONE SARCOMA CONSORTIUM (HIBISCUS)
Line Claude
Favorite
Cleary, Emmett

Mayo Clinic
(P 59) CHONDROSARCOMA OF THE FLAT BONES: DIFFERENTIAL SURVIVAL BETWEEN HIGH GRADE LESIONS OF THE PELVIS AND SCAPULA
Emmett Cleary
Favorite
(P 60) SKIP LESIONS IN CHONDROSARCOMA: IS WHOLE BONE IMAGING NECESSARY?
Emmett Cleary
Favorite
Clemente, Ottavia

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
(P 144) IMPLEMENTATION OF THE EUROPEAN CLINICAL TRIAL REGULATION: SURVEY OF THE ITALIAN SARCOMA GROUP CENTERS
Ottavia Clemente
Favorite
Clerici, Elena

Rozzano, Milan IRCCS Humanitas Research Hospital
(P 327) LEARNING CURVE ANALYSIS IN RETROPERITONEAL SARCOMA SURGERY
Elena Clerici
Favorite
(P 457) LONG-TERM FOLLOW-UP OF PATIENTS WITH ATYPICAL LIPOMATOUS TUMOR (ALT) TREATED WITH MARGINAL RESECTION IN A REFERRAL CENTER
Elena Clerici
Favorite
Clohisy, Denis

University of Minnesota
(P 167) FDG-PET-CT RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY PREDICTS LONG-TERM OUTCOME IN PATIENTS WITH SOFT TISSUE SARCOMA -- 15-YEAR FOLLOW-UP
Denis Clohisy
Favorite
Cloutier, Jeffrey

MD Anderson Cancer Center
(P 71) CHEMOTHERAPY AND PROGNOSTIC SIGNIFICANCE OF EXTENT OF DEDIFFERENTIATION IN DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA
Jeffrey Cloutier
Favorite
Cobrinik, David

Children's Hospital Los Angeles
(P 166) SARC038: A PHASE 2 STUDY OF REGORAFENIB IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH REFRACTORY OR RECURRENT OSTEOSARCOMA
David Cobrinik
Favorite
Cocchi, Claudia

Istituto Scientifico Romagnolo per lo studio dei Tumori "Dino Amadori", Preclinic and Osteoncology Unit, Meldola, Italy
(P 37) DISSECTING THE ROLE OF EXTRACELLULAR VESICLES IN THE MANAGEMENT OF GIST
Claudia Cocchi
Favorite
(P 253) THE EFFICACY OF MEDICATED PATCHES IN SOFT TISSUE SARCOMAS: IN-VITRO AND EX-VIVO VALIDATION.
Claudia Cocchi
Favorite
Coert, J.

UMC Utrecht
(P 316) THE ROLE OF RADIOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: A MULTICENTER COHORT STUDY
J. Coert
Favorite
(P 505) LOCAL RECURRENCE IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: A MULTICENTER COHORT STUDY
J. Coert
Favorite
Cohen-Gogo, Sarah

The Hospital for Sick Children
(P 81) OPTIMIZING EWING SARCOMA AND OSTEOSARCOMA BIOPSY ACQUISITION: CONSENSUS RECOMMENDATIONS FROM THE CHILDREN'S ONCOLOGY GROUP BONE TUMOR COMMITTEE
Sarah Cohen-Gogo
Favorite
Cohen, Jacob

University of Miami
(P 520) ORTHOPEDIC MANIFESTATIONS OF LYMPHOPROLIFERATIVE NEOPLASMS
Jacob Cohen
Favorite
Cohen, Sonia

Massachusetts General Hospital
(P 338) PREOPERATIVE RADIATION THERAPY IS NOT ASSOCIATED WITH ADVERSE POSTOPERATIVE OUTCOMES IN PATIENTS WITH RETROPERITONEAL SARCOMA
Sonia Cohen
Favorite
Cojocaru, Elena

Cambridge University Hospitals NHS Foundation Trust
(P 204) RADIATION-INDUCED ANGIOSARCOMA OF THE BREAST: RETROSPECTIVE ANALYSIS AT A REGIONAL TREATMENT CENTRE
Elena Cojocaru
Favorite
Colglazier, Roy

Duke University Hospital
(P 509) GIANT CELL TUMOR OF BONE IN THE PEDIATRIC POPULATION: A RETROSPECTIVE STUDY HIGHLIGHTING CASES OF METAPHYSEAL ONLY LOCATION AND INCREASED LOCAL RECURRENCE RATES IN SKELETALLY IMMATURE PATIENTS
Roy Colglazier
Favorite
Coll Zayas, Yaquelin

University of Florida
(P 99) M2 MACROPHAGE INFILTRATION IS ASSOCIATED WITH EARLY DISEASE RECURRENCE FOLLOWING CURATIVE INTENT SURGICAL RESECTION IN SOFT-TISSUE SARCOMAS
Yaquelin Coll Zayas
Favorite
Collaud, Stéphane

Cologne Merheim Hospital
(P 451) IMPACT OF TIME TO DIAGNOSIS - A PROSPECTIVE ANALYSIS OF THE EWING 2008 TRIAL
Stéphane Collaud
Favorite
Collier, Anderson

Nemours Children's Health
(P 444) TWO CASES OF BRAIN METASTASES OF CD99 POSITIVE SMALL ROUND BLUE CELL TUMORS
Anderson Collier
Favorite
(P 556) EVALUATION OF PALBOCICLIB (IBRANCE®) IN COMBINATION WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY EWING SARCOMA OR NEUROBLASTOMA
Anderson Collier
Favorite
Collini, Paola

Department of Advanced Diagnostics , Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 272) A COMPARATIVE ASSESSMENT OF SELINEXOR WITH TRABECTEDIN OR LURBINECTEDIN IN PATIENT-DERIVED XENOGRAFTS (PDX) OF DEDIFFERENTIATED LIPOSARCOMA (DDLPS)
Paola Collini
Favorite
(P 273) COMPARISON OF A PATIENT-DERIVED XENOGRAFTS (PDX) OF MYXOID PLEOMORPHIC LIPOSARCOMA (MPL) AND PLEOMORPHIC LIPOSARCOMA (PL) HIGHLIGHTS THE EFFECTIVENESS OF ERIBULIN IN A PDX OF MPL
Paola Collini
Favorite
(P 329) DISTANT METASTASIS IN RETROPERITONEAL LEIOMYOSARCOMA: TUMOR SIZE, GRADE AND MORE?
Paola Collini
Favorite
(P 333) SYSTEMIC TREATMENT IN INTRA-ABDOMINAL DESMOID-TYPE FIBROMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE CASE SERIES ANALYSIS
Paola Collini
Favorite
(P 431) TREATMENT STRATEGY AND PROGNOSTIC FACTORS IN EXTRASKELETAL EWING SARCOMA: AN INSTITUTIONAL RETROSPECTIVE ANALYSIS
Paola Collini
Favorite
(P 432) LONG-LASTING DISEASE CONTROL WITH TRABECTEDIN IN A CASE OF METASTATIC EWSR1::PATZ1 SARCOMA
Paola Collini
Favorite
(P 455) EXTRASKELETAL EWING SARCOMA: A MULTICENTRIC RETROSPECTIVE STUDY FROM THE ITALIAN SARCOMA GROUP
Paola Collini
Favorite
Collins, Mike

Foghorn Therapeutics
(P 271) PHARMACODYNAMICS AND MECHANISTIC IMPACTS OF FHD-609, A BROMODOMAIN-CONTAINING PROTEIN 9 DEGRADER, IN A PHASE 1 STUDY IN PATIENTS WITH ADVANCED SYNOVIAL SARCOMA OR SMARCB1-LOSS TUMORS
Mike Collins
Favorite
Collins, Natalie

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(P 438) ALVEOLAR RHABDOMYOSARCOMA WITH "BURKITT-LIKE" MORPHOLOGY IS ASSOCIATED WITH HIGH AMPLIFICATION OF MYCL
Natalie Collins
Favorite
(P 542) ENROLLMENT OF PEDIATRIC PARTICIPANTS WITH MAGE-A4-POSITIVE SOLID TUMORS IN A PHASE 1/2, OPEN-LABEL, BASKET TRIAL OF AFAMITRESGENE AUTOLEUCEL ("AFAMI-CEL")
Natalie Collins
Favorite
Colman, Matthew

Rush University Medical Center
(P 63) EVALUATION OF LOCAL RECURRENCE AND DIAGNOSTIC DISCORDANCE IN CHONDROSARCOMA PATIENTS UNDERGOING PREOPERATIVE BIOPSY
Matthew Colman
Favorite
(P 468) OPIATE USE AFTER TOTAL HIP ARTHROPLASTY FOR METASTATIC BONE DISEASE
Matthew Colman
Favorite
(P 506) THE EFFECT OF TIMING BETWEEN PRE-OPERATIVE EMBOLIZATION AND SURGERY: A RETROSPECTIVE ANALYSIS OF HYPERVASCULAR BONE METASTASES
Matthew Colman
Favorite
Colombo, Chiara

Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 14) PERCUTANEOUS CRYOABLATION OF PROGRESSING EXTRA-ABDOMINAL DESMOID TUMOURS
Chiara Colombo
Favorite
(P 126) CURRENT PRACTICE IN SPERMATIC CORD SARCOMA: ONCOLOGICAL TIMELINES AND OUTCOMES ACCORDING TO INITIAL RESECTIONS PERFORMED AT A LOCAL HOSPITAL VERSUS EARLY PATIENT REFERRAL TO A TERTIARY CENTRE.
Chiara Colombo
Favorite
(P 329) DISTANT METASTASIS IN RETROPERITONEAL LEIOMYOSARCOMA: TUMOR SIZE, GRADE AND MORE?
Chiara Colombo
Favorite
(P 333) SYSTEMIC TREATMENT IN INTRA-ABDOMINAL DESMOID-TYPE FIBROMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE CASE SERIES ANALYSIS
Chiara Colombo
Favorite
(P 363) Β-CATENIN MUTATIONS AND TRANSCRIPTOMIC REPROGRAMMING IN DESMOID FIBROMATOSIS (DF)
Chiara Colombo
Favorite
Colombo, Nicoletta

IEO
(P 328) REAL-LIFE EXPERIENCE OF PAZOPANIB IN PATIENTS WITH ADVANCED UTERINE LEIOMYOSARCOMA (U-LMS) FROM TWO REFERRAL ITALIAN CENTERS
Nicoletta Colombo
Favorite
Colombo, Piergiuseppe

IRCCS Humanitas Research Hospital
(P 433) A 20-YEAR MONOCENTER EXPERIENCE ON CLINICAL CHARACTERISTICS AND OUTCOME OF EXTRASKELETAL EWING SARCOMA.
Piergiuseppe Colombo
Favorite
Comandini, Daniela

Ospedale Policlinico San Martino-IRCCS
(P 144) IMPLEMENTATION OF THE EUROPEAN CLINICAL TRIAL REGULATION: SURVEY OF THE ITALIAN SARCOMA GROUP CENTERS
Daniela Comandini
Favorite
Comeau, Hannah

Dana-Farber / Boston Children's Cancer and Blood Disorders Center
(P 03) EVOLUTION OF CLINICALLY ACTIONABLE VARIANTS IN ADVANCED PEDIATRIC AND AYA BONE SARCOMAS
Hannah Comeau
Favorite
Conley, Anthony

MD Anderson Cancer Center
(P 36) CLINICO-GENOMIC ANALYSIS OF KIT/PDGFRA/SDH WILD-TYPE GASTROINTESTINAL STROMAL TUMORS IDENTIFIES POTENTIAL DRIVER MUTATIONS
Anthony Conley
Favorite
(P 66) PHASE I STUDY OF THE MUTANT IDH1 INHIBITOR IVOSIDENIB: LONG-TERM SAFETY AND CLINICAL ACTIVITY IN PATIENTS WITH CONVENTIONAL CHONDROSARCOMA
Anthony Conley
Favorite
(P 71) CHEMOTHERAPY AND PROGNOSTIC SIGNIFICANCE OF EXTENT OF DEDIFFERENTIATION IN DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA
Anthony Conley
Favorite
(P 83) CLINICO-GENOMIC PROFILING OF CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMAS REVEALS TP53 MUTATION TO BE ASSOCIATED WITH WORSE OUTCOMES
Anthony Conley
Favorite
(P 100) HISTOLOGY SPECIFIC INTRATUMORAL B-CELL BIOLOGY IN ALVEOLAR SOFT-PART SARCOMAS (ASPS) IN RESPONSE TO DURVALUMAB-TREMELIMUMAB (D-T)
Anthony Conley
Favorite
(P 123) DEDIFFERENTIATED LIPOSARCOMAS TREATED WITH IMMUNE CHECKPOINT BLOCKADE: THE MD ANDERSON EXPERIENCE
Anthony Conley
Favorite
(P 360) TP53 ALTERATIONS IN SARCOMAS: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Anthony Conley
Favorite
(P 394) LEIOMYOSARCOMA INTRATUMORAL MACROPHAGE INFILTRATES ARE ASSOCIATED WITH DISTINCT CLINICAL AND GENOMIC PRESENTATIONS
Anthony Conley
Favorite
(P 400) THE LANDSCAPE OF GENOMIC ALTERATIONS FROM 1494 SOFT TISSUE AND BONE SARCOMAS AT MD ANDERSON CANCER CENTER
Anthony Conley
Favorite
Connolly, Denise

University College London Hospital
(P 57) REAL-WORLD EXPERIENCE OF CABOZANTINIB IN PAEDIATRIC, TEENAGE AND YOUNG ADULT (TYA) AND ADULT METASTATIC BONE SARCOMA PATIENTS FROM THE LONDON SARCOMA SERVICE (LSS)
Denise Connolly
Favorite
Connolly, Elizabeth

Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, Australia. Faculty of medicine and health, University of Sydney, Sydney, Australia.
(P 189) INTERNATIONAL RETROSPECTIVE STUDY FROM THE ULTRA-RARE SARCOMA WORKING GROUP ON LOW-GRADE FIBROMYXOID SARCOMA AND SCLEROSING EPITHELIOD FIBROSARCOMA: OUTCOME OF ADVANCED DISEASE AND SYSTEMIC THERAPIES
Elizabeth Connolly
Favorite
Connolly, Elizabeth

Chris O Brien Lifehouse
(P 437) ULTRA-RARE UNDIFFERENTIATED SMALL ROUND CELL SARCOMA: HOW SHOULD WE TREAT THEM? AN ANALYSIS FORM THE GRACEFUL PROJECT
Elizabeth Connolly
Favorite
Conradi, Lena-Christin

Department of General, Visceral and Pediatric Surgery, University Medical Center Goettingen, 37075 Goettingen, Germany
(P 235) FUSION OF PREOPERATIVE IN SITU MAGNETIC RESONANCE IMAGING AND POSTOPERATIVE COMPUTED TOMOGRAPHY TO CORRELATE FUNCTIONAL IMAGING FEATURES AND PATHOLOGICAL CHARACTERISTICS OF SOFT TISSUE SARCOMA
Lena-Christin Conradi
Favorite
Consalvo, Sarah

Department of Orthopaedic Surgery, School of Medicine & Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany
(P 557) UNRAVELING THE ROLE OF LOCAL THERAPY FOR PATIENTS WITH OLIGOMETASTATIC SOFT TISSUE SARCOMA - A RETROSPECTIVE MULTICENTER TRIAL OF BAVARIAN UNIVERSITY HOSPITALS
Sarah Consalvo
Favorite
Constantinescu, David

University of Miami Miller School of Medicine
(P 485) SUBTROCHANTERIC NON-UNION AFTER INTRAMEDULLARY NAILING DUE TO PATHOLOGICAL FRACTURE:PROXIMAL FEMORAL REPLACEMENT AS A SALVAGE APPROACH
David Constantinescu
Favorite
Contreras, Carlo

The James Cancer Hospital / The Ohio State University
(P 314) PRE-OPERATIVE RADIATION THERAPY INCREASES ADHERENCE IN PATIENTS WITH HIGH-RISK EXTREMITY SOFT TISSUE SARCOMA
Carlo Contreras
Favorite
(P 347) INCIDENCE AND TIMING OF RECURRENCE AFTER ADJUVANT PALBOCICLIB IN COMPLETELY RESECTED RETROPERITONEAL LIPOSARCOMA
Carlo Contreras
Favorite
Conway, Sheila

Wake Forest University School of Medicine
(P 485) SUBTROCHANTERIC NON-UNION AFTER INTRAMEDULLARY NAILING DUE TO PATHOLOGICAL FRACTURE:PROXIMAL FEMORAL REPLACEMENT AS A SALVAGE APPROACH
Sheila Conway
Favorite
Cook, Chad

Duke University
(P 137) IMPACT OF SOCIAL DETERMINANTS OF HEALTH ON SARCOMA CARE: A SINGLE INSTITUTION EXPERIENCE
Chad Cook
Favorite
Coombs, Reilly

Medical College of Wisconsin-Central Wisconsin
(P 196) TOLERABILITY AND OUTCOMES FOR TREATMENT OF OLDER MYXOID LIPOSARCOMA POPULATION
Reilly Coombs
Favorite
Cope, Brandon

MD Anderson
(P 394) LEIOMYOSARCOMA INTRATUMORAL MACROPHAGE INFILTRATES ARE ASSOCIATED WITH DISTINCT CLINICAL AND GENOMIC PRESENTATIONS
Brandon Cope
Favorite
Coppadoro, Beatrice

Department of Pediatric Haematology and Oncology, University Hospital of Padua
(P 209) PROGNOSTIC VALUE OF EARLY RADIOLOGIC TUMOUR VOLUME RESPONSE IN RHABDOMYOSARCOMA; RESULTS OF THE EUROPEAN PAEDIATRIC SOFT TISSUE SARCOMA STUDY GROUP RMS 2005 STUDY
Beatrice Coppadoro
Favorite
Coppola, Enzo

The Ohio State University
(P 305) A NEW MOUSE MODEL FOR TESTING SPLICE-SWITCHING THERAPIES IN RHABDOMYOSARCOMA
Enzo Coppola
Favorite
Coppola, Marina

Pharmacy Unit, Veneto Institute of Oncology IOV - IRCCS
(P 171) SEX DIFFERENCES IN OUTCOMES AND TOXICITY IN PATIENTS TREATED FOR SARCOMA IN A REFERENCE CENTER
Marina Coppola
Favorite
Coquillard, Cristin

Northwestern Medicine
(P 480) TARGETED MUSCLE REINNERVATION FOR HIP DISARTICULATION - EVALUATION OF EARLY FUNCTIONAL OUTCOMES
Cristin Coquillard
Favorite
Cornmark, Louise

Lund University
(P 371) DISRUPTION OF THE TP53 LOCUS IN OSTEOSARCOMA LEADS TO TP53 PROMOTER GENE FUSIONS AND RESTORATION OF PARTS OF THE TP53 SIGNALLING PATHWAY
Louise Cornmark
Favorite
Corona, Juan Antonio

Hospital Clinico san Carlos
(P 149) PSYCOLOGICAL SNAPSHOT OF SARCOMA PATIENTS FROM AN ACADEMIC, UNIVERSITY CENTER, HOSPITAL CLÍNICO SAN CARLOS (HCSC), MADRID, A SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN
Juan Antonio Corona
Favorite
Corradini, Nadège

CENTRE LEON BERARD
(P 382) NTRK1/2/3 FUSIONS DETECTION USING RNA-SEQ IN MESENCHYMAL TUMORS REVEALS ULTRA-RARE AND HISTO-SPECIFIC TARGETABLE ALTERATIONS: EXPERIENCE OF AN EXTENSIVE ROUTINE RESEARCH PROGRAM.
Nadège Corradini
Favorite
(P 435) ONCOGENIC FUSION YWHAE::NUTM2 DISRUPT EP300/BCOR INTERACTION
Nadège Corradini
Favorite
Corradini, Nadege

Institut d'Hematologie et d'Oncologie Pédiatrique, Centre Léon Bérard
(P 75) REAL-WORLD DATA ON REGORAFENIB AND CABOZANTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED OSTEOSARCOMA AND EWING SARCOMA INCLUDED IN THE SACHA-FRANCE STUDY
Nadege Corradini
Favorite
(P 202) INFLAMMATORY MYOFIBROBLASTIC TUMOUR WITH ROS1 GENE FUSIONS IN CHILDREN AND YOUNG ADOLESCENTS
Nadege Corradini
Favorite
(P 212) REPORT ON THE EWING SARCOMA PATIENTS ENROLLED IN ARM D OF THE ACSE-ESMART TRIAL: PHASE I/II STUDY OF THE PARP INHIBITOR OLAPARIB IN COMBINATION WITH IRINOTECAN IN CHILDREN WITH ADVANCED MALIGNANCIES
Nadege Corradini
Favorite
Cortes, Jose Antonio

Hospital Clinico san Carlos
(P 149) PSYCOLOGICAL SNAPSHOT OF SARCOMA PATIENTS FROM AN ACADEMIC, UNIVERSITY CENTER, HOSPITAL CLÍNICO SAN CARLOS (HCSC), MADRID, A SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN
Jose Antonio Cortes
Favorite
Costa, Felipe

AC Camargo Cancer Center
(P 192) ROLE OF MAGNETIC RESONANCE IMAGING IN THE PREDICTION OF HISTOLOGICAL GRADE IN SOFT TISSUE SARCOMAS.
Felipe Costa
Favorite
Costa, Philippos

Yale University
(P 158) SORAFENIB OR ANTHRACYCLINE-BASED CHEMOTHERAPY IN ADULT PATIENTS WITH PROGRESSIVE DESMOID TUMORS
Philippos Costa
Favorite
Costas casal de Faria, Fernanda

The Ohio State University Comprehensive Cancer Center
(P 335) EXTRACELLULAR VESICLE MDM2 DNA AS A BIOMARKER OF TUMOR PRESENCE AND RECURRENCE IN RETROPERITONEAL LIPOSARCOMA
Fernanda Costas casal de Faria
Favorite
Costelloe, Colleen

MD Anderson cancer center
(P 221) EARLY RESULTS IN NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING IN THE ASSESSMENT OF RESPONSE AND PROGRESSION IN DESMOID FIBROMATOSIS: PILOT STUDY IN A SPECIALIZED CANCER INSTITUTION
Colleen Costelloe
Favorite
(P 239) CANCER RADIOMIC AND PERFUSION IMAGING (CARPI) AUTOMATED FRAMEWORK: VALIDATION ON MUSCULOSKELETAL TUMORS IN A SPECIALIZED CANCER CENTER
Colleen Costelloe
Favorite
(P 356) BASELINE AND POST-TREATMENT ADVANCED MRI OF EXTREMITIES SOFT-TISSUE NON-MYXOID UNDIFFERENTIATED PLEOMORPHIC SARCOMA.
Colleen Costelloe
Favorite
(P 357) APPARENT DIFFUSION COEFFICIENT (ADC) HIGH-ORDER RADIOMICS OF BASELINE AND POST-TREATMENT ADVANCED MRI OF EXTREMITY SOFT-TISSUE NON-MYXOID UNDIFFERENTIATED PLEOMORPHIC SARCOMA.
Colleen Costelloe
Favorite
(P 358) CONTRAST-ENHANCED SUSCEPTIBILITY IMAGING (CE-SWI) MORPHOLOGIC, FIRST & HIGH-ORDER RADIOMIC FEATURES VALUE IN ASSESSING TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Colleen Costelloe
Favorite
(P 359) ROLE OF PERFUSION WEIGHTED IMAGING WITH DYNAMIC CONTRAST ENHANCED (PWI/DCE) FOR THE TREATMENT ASSESSMENT OF EXTREMITY SOFT-TISSUE NON-MYXOID UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Colleen Costelloe
Favorite
Cote, Gregory

Mass General Cancer Center
(P 66) PHASE I STUDY OF THE MUTANT IDH1 INHIBITOR IVOSIDENIB: LONG-TERM SAFETY AND CLINICAL ACTIVITY IN PATIENTS WITH CONVENTIONAL CHONDROSARCOMA
Gregory Cote
Favorite
(P 178) INITIAL RESULTS FROM A PHASE 1 STUDY OF CFT8634, A NOVEL BIFUCTIONAL DEGRADATION ACTIVATING COMPOUND (BIDAC) DEGRADER OF BRD9, IN SYNOVIAL SARCOMA AND SMARCB1-NULL TUMORS
Gregory Cote
Favorite
(P 338) PREOPERATIVE RADIATION THERAPY IS NOT ASSOCIATED WITH ADVERSE POSTOPERATIVE OUTCOMES IN PATIENTS WITH RETROPERITONEAL SARCOMA
Gregory Cote
Favorite
Cottereau, edouard

CHU Tours
(P 201) PLEOMORPHIC RHABDOMYOSARCOMAS: A NEW ENTITY ASSOCIATED WITH LYNCH SYNDROME? FIRST RESULTS OF SARCLYNCH NATIONAL STUDY
edouard Cottereau
Favorite
Coudert, Marie

ICP
(P 201) PLEOMORPHIC RHABDOMYOSARCOMAS: A NEW ENTITY ASSOCIATED WITH LYNCH SYNDROME? FIRST RESULTS OF SARCLYNCH NATIONAL STUDY
Marie Coudert
Favorite
Coukos, George

Ludwig Institut
(P 535) THERAGNOSTICS IN SOFT TISSUE SARCOMA USING A VASCULAR DISCRUPTION APPROACH
George Coukos
Favorite
Covello, Eva

IRCCS Humanitas Research Hospital
(P 457) LONG-TERM FOLLOW-UP OF PATIENTS WITH ATYPICAL LIPOMATOUS TUMOR (ALT) TREATED WITH MARGINAL RESECTION IN A REFERRAL CENTER
Eva Covello
Favorite
Coward, Victoria

The Lunenfeld-Tanenbaum Research Institute
(P 249) INVESTIGATING CLINICAL FACTORS ASSOCIATED WITH THE ESTABLISHMENT OF SUCCESSFUL PRIMARY HUMAN SOFT TISSUE SARCOMA CELL LINES
Victoria Coward
Favorite
(P 352) DETERMINING THE CONTRIBUTIONS OF STAT1 TO THE UPS ANTI-TUMOR MICROENVIRONMENT
Victoria Coward
Favorite
Cox, Jennifer

University of Mississippi Medical Center
(P 444) TWO CASES OF BRAIN METASTASES OF CD99 POSITIVE SMALL ROUND BLUE CELL TUMORS
Jennifer Cox
Favorite
Crago, Aimee

Memorial Sloan Kettering Cancer Center
(P 24) COMPREHENSIVE ANALYSIS OF THE GENOMIC LANDSCAPE AND CLINICAL BEHAVIOR IN GIST USING NEXT GENERATION SEQUENCING (NGS, MSK-IMPACT)
Aimee Crago
Favorite
(P 343) STEREOTACTIC BODY RADIATION THERAPY (SBRT) IN ADVANCED/RECURRENT RETROPERITONEAL SARCOMA: PRELIMINARY RESULTS
Aimee Crago
Favorite
Craig, Brian

Children's Wisconsin, Medical College of Wisconsin
(P 81) OPTIMIZING EWING SARCOMA AND OSTEOSARCOMA BIOPSY ACQUISITION: CONSENSUS RECOMMENDATIONS FROM THE CHILDREN'S ONCOLOGY GROUP BONE TUMOR COMMITTEE
Brian Craig
Favorite
Cranmer, Lee

University of Washington/Fred Hutchinson Cancer Center
(P 67) GENOMIC CHARACTERIZATION OF CHONDROSARCOMA: A RARE SARCOMA WITH CLINICAL RESPONSES TO IMMUNE CHECKPOINT INHIBITION
Lee Cranmer
Favorite
(P 177) ANGIOSARCOMA: AN INCREASING PROBLEM IN THE UNITED STATES
Lee Cranmer
Favorite
(P 184) PHASE 1B TRIAL OF CAMSIRUBICIN, A NOVEL DOXORUBICIN ANALOG, WITH CONCOMITANT PEGFILGRASTIM IN SUBJECTS WITH ADVANCED SOFT TISSUE SARCOMA TO IDENTIFY A NEW MTD/RP2D
Lee Cranmer
Favorite
(P 206) A SINGLE-ARM, PHASE II STUDY OF NEOADJUVANT PEMBROLIZUMAB COMBINED WITH RADIOTHERAPY IN THE PRIMARY TREATMENT OF SOFT TISSUE SARCOMAS.
Lee Cranmer
Favorite
(P 540) PHASE 2, MULTICENTER, OPEN-LABEL BASKET TRIAL OF NAB-SIROLIMUS FOR MALIGNANT SOLID TUMORS HARBORING PATHOGENIC INACTIVATING ALTERATIONS IN TSC1 AND TSC2 (PRECISION I)
Lee Cranmer
Favorite
Crawford, Brooke

University of Miami
(P 154) BARRIERS TO CARE FOR MUSCULOSKELETAL TUMORS
Brooke Crawford
Favorite
(P 520) ORTHOPEDIC MANIFESTATIONS OF LYMPHOPROLIFERATIVE NEOPLASMS
Brooke Crawford
Favorite
Crespo, Ana Maria

Hospital Clinico san Carlos
(P 149) PSYCOLOGICAL SNAPSHOT OF SARCOMA PATIENTS FROM AN ACADEMIC, UNIVERSITY CENTER, HOSPITAL CLÍNICO SAN CARLOS (HCSC), MADRID, A SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN
Ana Maria Crespo
Favorite
Creytens, David

Ghent University Hospital
(P 55) RELATIVE WASH-IN RATE ON DYNAMIC CONTRAST-ENHANCED MRI AS A NEW PROGNOSTIC FACTOR IN PATIENTS WITH OSTEOSARCOMA; A POSSIBLE TOOL FOR PERSONALIZED SARCOMA-CARE?
David Creytens
Favorite
(P 291) DEVELOPMENT OF A LIVE TISSUE SARCOMA BIOBANK TO SUPPORT THE CREATION OF PATIENT-DERIVED TRANSLATIONAL MODELS
David Creytens
Favorite
(P 295) ORTHOTOPIC XENOGRAFTS OF PAIRED SARCOMA PRIMARY TUMOUR, LOCAL RELAPSE AND METASTATIC SITES REVEALS PHENOTYPIC HETEROGENEITY IN A MINIMAL RESIDUAL DISEASE MODEL
David Creytens
Favorite
Cribbs, Adam

University of Oxford
(P 04) THE CELL ATLAS OF CLEAR CELL SARCOMA
Adam Cribbs
Favorite
Cripe, Timothy

Nationwide Children's Hospital
(P 94) DEVELOPING NOVEL OLIGONUCLEOTIDE THERAPIES TO MODULATE INSULIN RECEPTOR ALTERNATIVE SPLICING IN PEDIATRIC BONE SARCOMAS
Timothy Cripe
Favorite
(P 107) TRABECTEDIN AUGMENTS ONCOLYTIC HERPES SIMPLEX VIROIMMUNOTHERAPY EFFICACY IN PRECLINCAL BONE SARCOMA MODELS THROUGH ENHANCED IMMUNE-MEDIATED MECHANISMS
Timothy Cripe
Favorite
(P 125) MYELOMODULATORY TREATMENTS AUGMENT THE THERAPEUTIC BENEFIT OF ONCOLYTIC VIRUS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS BY MODULATING THE TUMOR MICROENVIRONMENT
Timothy Cripe
Favorite
(P 305) A NEW MOUSE MODEL FOR TESTING SPLICE-SWITCHING THERAPIES IN RHABDOMYOSARCOMA
Timothy Cripe
Favorite
Cristalli, Camilla

IRCCS Istituto Ortopedico Rizzoli
(P 85) TARGETING CD99 ELICITS EWING SARCOMA CELL PHAGOCYTOSIS BY UNDIFFERENTIATED AND M2-LIKE MACROPHAGES AND INDUCES MACROPHAGE POLARIZATION TOWARD A M1-LIKE PHENOTYPE
Camilla Cristalli
Favorite
Cristofaro, Caroline

University of Toronto
(P 443) SURGICAL RESECTION OF EXTREMITY EWING'S SARCOMA BASED ON POST-CHEMOTHERAPY TUMOUR VOLUME RESULTS IN SAFE MARGINS
Caroline Cristofaro
Favorite
CROMBE, Amandine

CHU Bordeaux
(P 523) IN-BETWEEN SARCOMA: A CATEGORY OF HIGH RISK OF RECURRENCE AND POOR OUTCOME
Amandine CROMBE
Favorite
Crompton, Brian

Dana-Farber Cancer Institute
(P 166) SARC038: A PHASE 2 STUDY OF REGORAFENIB IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH REFRACTORY OR RECURRENT OSTEOSARCOMA
Brian Crompton
Favorite
(P 438) ALVEOLAR RHABDOMYOSARCOMA WITH "BURKITT-LIKE" MORPHOLOGY IS ASSOCIATED WITH HIGH AMPLIFICATION OF MYCL
Brian Crompton
Favorite
Crotti, Elisa

Istituto Clinico Humanitas Humanitas Cancer Center
(P 144) IMPLEMENTATION OF THE EUROPEAN CLINICAL TRIAL REGULATION: SURVEY OF THE ITALIAN SARCOMA GROUP CENTERS
Elisa Crotti
Favorite
Crotty, Tom

St Vincents University Hospital
(P 155) THE IMPACT OF THE ROLE OF A SARCOMA ADVANCED NURSE PRACTITIONER (ANP) BIOPSY CLINIC IN IMPROVING PATIENT ACCESS TO SARCOMA SERVICES
Tom Crotty
Favorite
(P 156) PATIENT REPORTED EXPERIENCES WITHIN THE IRISH SARCOMA GROUP
Tom Crotty
Favorite
(P 217) CONTEMPORARY TREATMENT PATTERNS AND OUTCOMES IN THE MANAGEMENT OF ANGIOSARCOMA IN IRELAND
Tom Crotty
Favorite
Crowley, Timothy

The Newcastle upon Tyne Hospitals NHS Foundation Trust
(P 228) WHAT IS THE SIGNIFICANCE OF INDETERMINATE PULMONARY NODULES IN HIGH GRADE SOFT TISSUE SARCOMA? A RETROSPECTIVE COHORT STUDY
Timothy Crowley
Favorite
Crown, John

SVHG
(P 213) EXPERIENCE WITH THE USE OF TRABECTEDIN IN ADVANCED SOFT TISSUE SARCOMA IN IRELAND
John Crown
Favorite
Cruzado, Juan Antonio

Universidad Complutense de Madrid
(P 149) PSYCOLOGICAL SNAPSHOT OF SARCOMA PATIENTS FROM AN ACADEMIC, UNIVERSITY CENTER, HOSPITAL CLÍNICO SAN CARLOS (HCSC), MADRID, A SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN
Juan Antonio Cruzado
Favorite
Cruz, Josefina

HU Canarias
(P 113) IMMUNOSARC II: A SPANISH SARCOMA GROUP (GEIS) PHASE IB TRIAL OF DOXORUBICIN AND DACARBAZINE PLUS NIVOLUMAB IN FIRST LINE OF ADVANCED LEIOMYOSARCOMA
Josefina Cruz
Favorite
(P 142) THE SARCOMA EUROPEAN AND LATIN AMERICAN NETWORK (SELNET) PROJECT: OVERVIEW OF THE MAIN RESULTS OF THE SELNET REGISTRY
Josefina Cruz
Favorite
(P 175) TRABECTEDIN PLUS RADIOTHERAPY ON SYMPHTOMATIC ADVANCED SARCOMA PATIENTS, RESULTS FROM THE SYNERGIAS STUDY: A SPANISH GROUP FOR RESEARCH IN SARCOMA (GEIS) PHASE II STUDY
Josefina Cruz
Favorite
Cuenca, Concepcion

Hospital Clinico san Carlos
(P 149) PSYCOLOGICAL SNAPSHOT OF SARCOMA PATIENTS FROM AN ACADEMIC, UNIVERSITY CENTER, HOSPITAL CLÍNICO SAN CARLOS (HCSC), MADRID, A SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN
Concepcion Cuenca
Favorite
Currier, Mark

Nationwide Children's Hospital
(P 107) TRABECTEDIN AUGMENTS ONCOLYTIC HERPES SIMPLEX VIROIMMUNOTHERAPY EFFICACY IN PRECLINCAL BONE SARCOMA MODELS THROUGH ENHANCED IMMUNE-MEDIATED MECHANISMS
Mark Currier
Favorite
(P 125) MYELOMODULATORY TREATMENTS AUGMENT THE THERAPEUTIC BENEFIT OF ONCOLYTIC VIRUS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS BY MODULATING THE TUMOR MICROENVIRONMENT
Mark Currier
Favorite
Cyprovà, Sona

Motol Children's Hospital
(P 451) IMPACT OF TIME TO DIAGNOSIS - A PROSPECTIVE ANALYSIS OF THE EWING 2008 TRIAL
Sona Cyprovà
Favorite
Czarnecka, Anna

Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
(P 162) LONG TERM SAFETY AND EFFICACY OF COMBINED DOXORUBICIN-IFOSFAMIDE CHEMOTHERAPY WITH PREOPERATIVE HYPOFRACTIONATED RADIOTHERAPY IN MARGINALLY RESECTABLE SOFT TISSUE SARCOMAS
Anna Czarnecka
Favorite
(P 222) EXPLORING THE IMPACT OF NGS ON DIAGNOSTICS AND TREATMENT OF SARCOMA: INSIGHTS FROM REAL-WORLD DATA ACROSS MULTIPLE INSTITUTIONS IN EUROPE
Anna Czarnecka
Favorite